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ABSTRACT
Background: The Affordable Care Act (ACA) waived deductibles and eliminated
coinsurance for colonoscopies for Medicare beneficiaries beginning on January 1, 2011.
This study investigated the effect of the ACA’s removing of financial barriers on the
receipt of colonoscopies among insured elderly, who are predominantly covered by
Medicare. Moreover, this study examined how income-related disparities in colonoscopy
use have changed over the past decade and attempted to quantify various contributions to
income-related disparity in the use of colonoscopies among insured elderly.
Methods: Five cycles (2008, 2010, 2012, 2014, and 2016) of the Behavioral Risk Factor
Surveillance System (BRFSS) were utilized to examine the receipt of colonoscopies
among insured elderly aged 65 to 75 prior to the implementation of ACA and then again
afterwards. To examine income-related disparities in the use of colonoscopies,
individuals aged 65 to 75 were included, and the Concentration Index (CI) was calculated
before and after implementation of the ACA. To identify and quantify the contribution of
each factor, decomposition of the CIs was conducted.
Results: Of 349,899 eligible elderly insured in the age group 65 to 75 years, 236,275
(68%) had received a colonoscopy in the previous 10 years. The receipt of colonoscopies
increased from 63% in the pre-ACA years to 70% in the post-ACA years (p<.001).
Compared with the pre-ACA period, colonoscopy uptake during post-ACA years shows
an odds ratio of 1.15 (95% confidence limit [CI] = 1.08-1.22, p<.001) after adjusting for
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time dependent improvements in colonoscopies and other relevant factors. CIs indicated
that disparities in colonoscopy use were lessened after the implementation of the ACA.
Decomposition analyses showed that whereas decreases in disparities derived largely
from income and educational levels, higher levels of income and educational attainment
continue to be major contributors to the observed disparities in colonoscopy use.
Conclusions: Following the implementation of the ACA, a statistically significant
increases in colonoscopy use was observed and may contribute to the observed decreases
in the disparity of colonoscopy use. This suggests that eliminating financial barriers to
access has improved the CRC screening rate, but achieving the national goal of 80%
coverage and the Healthy People 2020 goal will require additional interventions to
encourage higher screening levels.
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CHAPTER 1
INTRODUCTION

Colorectal cancer (CRC) is the second leading cause of cancer deaths for both
men and women in the United States (Siegel, Miller et al. 2017). There were an estimated
135,430 new cases and 50,260 deaths from CRC in 2017 (Siegel, Miller et al. 2017).
Early detection of CRC through routine screening has been demonstrated to be effective
in reducing the incidence of and mortality from this disease (Edwards, Ward et al. 2010,
Lin, Piper et al. 2016, Siegel, Miller et al. 2017). The U.S. Preventive Services Task
Force (USPSTF) strongly recommends screening for CRC beginning at the age of 50 and
continuing until the age of 75 for individuals at average risk, implying that increases in
screening for CRC result in decreases for CRC mortality (Koretz 2016, Lin, Piper et al.
2016, US Preventive Services Task Force 2016).
USPSTF has recommended a number of different screening tests for use in
detecting early-stage CRC and preventing incident cases, including 1) flexible
sigmoidoscopy every 5 years, 2) FIT-DNA every 1 or 3 years, 3) fecal occult blood test
or fecal immunochemical testing every year, 4) CT colonography every 5 years, 5)
flexible sigmoidoscopy every 10 years plus FIT every year, and (6) colonoscopy every 10
years (US Preventive Services Task Force 2016). The USPSTF recommends screening
using any of the accepted methods, as any type of screening test would be better than no
screening at all (Atkin, Edwards et al. 2010, Quintero, Castells et al. 2012, Patel and
1

Kilgore 2015, US Preventive Services Task Force 2016). All the screening options are
not equally attractive to all individuals; depending upon health history and preferences of
individuals, the choices may differ significantly. However, from a clinical perspective,
colonoscopy is the preferred method, because a colonoscopy allows doctors to examine
the entire length of the colon and remove all cancers and precancerous polyps during a
single procedure (Levin, Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et
al. 2016). Colonoscopy is also recommended as a follow-up when another CRC screening
is positive. Moreover, colonoscopy has been validated in a randomized trial to have a
mortality reduction benefit (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz
2016, US Preventive Services Task Force 2016).
The mortality rate from CRC has decreased steadily since 1980 (Weir, Thompson
et al. 2015, Siegel, Miller et al. 2017), which may be attributable partially to removal of
pre-cancerous, adenomatous polyps at an early stage based on diagnosis of CRC and
partially to widespread use of colonoscopies or other screening approaches (Cunningham,
Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin, Tully et al. 2017,
Partin, Gravely et al. 2017). Nonetheless, self-reported CRC screening rates in the
National Health Interview Survey are at 62%, and the National Committee for Quality
Assurance (NCQA) indicates that 60% of commercial insurance members and 69% of
Medicare plan members received an appropriate CRC screening in 2016 (Paskett and
Khuri 2015, White, Thompson et al. 2017). Moreover, Behavioral Risk Factor
Surveillance System (BRFSS) data indicate that around 65% of adults aged 50 to 75
reported having had one of the colorectal screening tests recommended by USPSTF, and
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around 60% of adults aged 50 to 75 had received a colonoscopy within the last 10 years
(Joseph, King et al. 2012, Liss and Baker 2014).
The US Department of Health and Human Services (HHS) initiated Healthy
People 2020 (HP2020), which covered several objectives for reducing cancer mortality.
Each objective was assigned a baseline measure in 2007 and a target to be achieved by
2020. HP2020 calls for a 15% reduction in death rates from 2007 to 2020 for CRC (Weir,
Thompson et al. 2015). Moreover, the National Colorectal Cancer Roundtable (NCCRT)
initiated a goal to increase the CRC screening rate to 80% in the eligible population by
2018 (Karlitz, Oliphant et al. 2017). Achieving this goal would avert 280,000 new cases
of CRC and 200,000 deaths from the disease by 2030, and 24.4 million people would be
screened (Fedewa, Ma et al. 2015, Meester, Doubeni et al. 2015). Nonetheless, the
aforementioned screening rates are lower than the use of preventive interventions for
other screening-amenable cancers, below the 80% coverage of the CRC screening target,
and below the HP2020 target of 71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al.
2017, White, Thompson et al. 2017).
One potential barrier to CRC screening is the associated out-of-pocket financial
costs (Howard, Guy et al. 2014). The financial costs may significantly dampen patients’
willingness to adopt any preventive procedures, including any of the recommended CRC
screenings. This is especially true for colonoscopies, which usually involved relatively
high cost-sharing requirements prior to the ACA policy change in 2011 (Klabunde, Riley
et al. 2004, Hamman and Kapinos 2015). Previous studies have shown that cost-sharing
reduces preventive health care use, including the use of highly effective screening tests
(Busch, Barry et al. 2006, Goodwin and Anderson 2012). One study found that waiving
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coinsurance for colonoscopies resulted in an 18% increase in screenings (Khatami, Xuan
et al. 2012).
To address the negative consequences of financial barriers on the use of
preventive services and to promote CRC screening, the Affordable Care Act (ACA)
requires all non-grandfathered private health plans to offer coverage of CRC screening
without cost-sharing. Consistent with the ACA policy requirement, beginning January 1,
2011, Medicare waived Part B deductibles for all colonoscopies and eliminated
coinsurance for screening colonoscopies, although not for diagnostic ones (Howard, Guy
et al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face
unexpected out-of-pocket liabilities when a polyp is detected and removed during a
colonoscopy, in which case the patients are billed a copay. Medicare beneficiaries are
also responsible for Part B deductibles and coinsurance when a colonoscopy is performed
as part of a two-step screening process after another CRC screening is positive (Howard,
Guy et al. 2014). Nevertheless, the ACA policy change, in general, implies that the
elderly insured population should see significant reductions in out-of-pocket expenses
associated with colonoscopies.
Research on the effects of cost-sharing reductions to utilization of preventive
health care has received significant attention from researchers and policy makers; but
surprisingly, only a few studies have assessed the effect of cost-sharing reduction on
colonoscopies among the elderly insured population, including the Medicare
beneficiaries, following the implementation of the ACA (Hamman and Kapinos 2015,
Cooper, Kou et al. 2016). The few studies that have examined this issue used a very short
time-frame beginning with the implementation of the ACA, so they may have
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underestimated the effects of the ACA cost-sharing reduction. Furthermore, these studies
yielded variable results concerning the receipt of colonoscopies following the changes in
coverage post-ACA (Fedewa, Goodman et al. 2015, Hamman and Kapinos 2015, Cooper,
Kou et al. 2016); and they have not been able to determine whether eliminating financial
barriers might have helped socioeconomically vulnerable Medicare beneficiaries more
than other groups. Moreover, these studies have not examined the ACA’s impact on
screening disparities among the elderly insured. It is true that some of the
socioeconomically vulnerable elderly may be enrolled in Medicaid; and in that case,
these individuals would have received colonoscopies with no out-of-pocket expenses in
the pre-ACA years. However, this should not affect the results significantly as almost all
elderly are enrolled in Medicare and only a relatively small percentage are enrolled in
Medicaid (Medicaid only or dually eligible) (Grabowski, 2012).
Thus, to address these gaps in current research, this study aimed to examine the
changes in colonoscopy use among the elderly insured population, including Medicare
beneficiaries, following the implementation of the ACA policy for preventive services.
Our hypothesis was that the elderly insured population have a greater likelihood of
undergoing colonoscopies following the implementation of the ACA. We also wanted to
determine whether the ACA policy changes have helped the socioeconomically
vulnerable elderly more than others.
This study consists of two manuscripts. The first manuscript of the dissertation
examined the effect of the ACA cost-sharing reduction on the receipt of colonoscopy
among the elderly insured population. This study aimed to examine how the ACA costsharing reduction has changed colonoscopy use among the elderly insured and to assess
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the various factors that affect the receipt of colonoscopies. The second manuscript
examined how disparities in colonoscopy use in the United States have changed over the
past decade, in line with the implementation of the ACA and attempted to quantify the
contributions to the disparity in the use of colonoscopies among elderly insured.
The dissertation is organized into five chapters, including two manuscripts.
Chapter 1 provides the background information and the rationale of the study. Chapter 2
describes a review of the scientific literature that provides a current understanding of
colorectal cancer screening and of efforts to improve colorectal cancer screening.
Knowledge gaps are also stated. Chapter 3 presents the methodology of the study.
Chapter 4 presents the two manuscripts. Chapter 5 includes the overall discussion,
conclusions, and implications for future research.
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CHAPTER 2
BACKGROUND AND SIGNIFICANCE

2.1 Colorectal Cancer
Colorectal cancer (CRC) is a type of cancer that develops in the colon or rectum,
and over two thirds of CRCs in the United States are found in the colon (Murphy, Harlan
et al. 2015). Most forms of CRC grow slowly over a decade or more. CRC symptoms
depend on the location and size of the cancer. Prior studies have shown that symptoms,
such as changes in bowel habits, changes in stool consistency, blood in the stool, rectal
bleeding, abdominal discomfort, and unintended weight loss, are associated with CRC;
but they are also common in individuals without cancer, which indicates poor sensitivity
in self-diagnosis of CRC (Jellema, van der Windt et al. 2010, Astin, Griffin et al. 2011,
Williams, Cubiella et al. 2016). Symptoms alone cannot be the determinant of CRC;
therefore, identifying patients who should be referred for diagnostic colonoscopy remains
a challenge (Williams, Cubiella et al. 2016).
There were an estimated 135,430 new cases of and 50,260 deaths from CRC in
2017 (Siegel, Miller et al. 2017). Although the majority of new cases develop in people
aged 65 or older, 45% of men and 39% of women are younger than age 65 years old at
diagnosis (Siegel, Miller et al. 2017). Among men, 18% of cases and 27% of deaths
7

develop in those aged 80 or older, compared with 27% of cases and 40% of deaths,
respectively, among women (Siegel, Miller et al. 2017). The mean age at death from
CRC is 73 years (US Preventive Services Task Force 2016). Incidence and mortality rates
have been decreasing for several decades as a consequence of historical changes in risk
factors, the introduction and dissemination of screening tests, and advancements in
treatment (Edwards, Ward et al. 2010, Lin, Piper et al. 2016, Martin, Tully et al. 2017).
CRC is the third most commonly diagnosed malignancy and the second leading
cause of cancer deaths for both men and women in the United States (Siegel, Miller et al.
2017). From 2009-2013, the annual age-standardized incidence rate for CRC in the
United States was 41 per 100,000 persons, and from 2010-2014 the mortality rate was 15
per 100,000 persons (Siegel, Miller et al. 2017). Despite the fact that the lifetime risk of
disease is no different in men (5%) than in women (4%), the incidence rate was 30%
higher in men, and the mortality rate was 40% higher in men (Siegel, Miller et al. 2017).
Sex disparities also vary by age. For example, the incidence rate was 132 per 100,000
men aged 55 to 74 years and 91 per 100,000 women aged 55 to 74 years (Siegel, Miller et
al. 2017). The higher rates in men can be explained by differences in exposures to risk
factors and sex hormones, as well as complex interactions between these forces (Murphy,
Devesa et al. 2011).
CRC incidence and mortality rates differ considerably by race and ethnicity
(Siegel, Miller et al. 2017). Among the five major racial and ethnic subgroups (NonHispanic white, Non-Hispanic black, Asian Americans and Pacific Islanders, Native
Americans and Native Alaskans, and Hispanic), rates were highest in non-Hispanic
blacks and lowest in Asian Americans and Paciﬁc Islanders. Non-Hispanic blacks have
8

the highest incidence of and mortality rates from CRC and almost double the CRC
mortality rate of other racial and ethnic minorities (Williams, Cubiella et al. 2016). From
2009 through 2013, CRC incidence rates were 49 per 100,000 non-Hispanic blacks, 40
per 100,000 non-Hispanic whites, and 32 per 100,000 Asian Americans and Paciﬁc
Islanders (Siegel, Miller et al. 2017). The magnitude of the disparity in mortality rates
was much greater. Between 2010 and 2014, CRC death rates were 21 per 100,000 nonHispanic blacks, 15 per 100,000 non-Hispanic whites, and 10 per 100,000 Asian
Americans and Paciﬁc Islanders (Siegel, Miller et al. 2017). The higher rates for nonHispanic blacks can be explained by disproportionately low socioeconomic status, which
is associated with a higher risk of CRC incidence and death (Doubeni, Laiyemo et al.
2012, Grzywacz, Hussain et al. 2017). Low socioeconomic status can be defined based
on several measures: the highest grade or level of schooling completed (less than high
school diploma), job status (unemployed or in a managerial position), income below the
federal poverty level, reliance on public assistance, lack of personal transportation, or
income below $30,000 (Doubeni, Laiyemo et al. 2012). The official poverty measure was
developed in the 1960s in conjunction with President Lyndon Johnson’s War on Poverty.
Each September the U.S. Census Bureau releases an update on the national poverty rate
based on data from the prior year (DeNavas-Walt, Proctor et al. 2014). The Census
Bureau uses a set of money income thresholds that vary by family size and composition
to determine the number of Americans living in poverty. The official poverty definition
uses money income before taxes and does not include capital gains or noncash benefits
such as public housing, Medicaid, and food stamps (Mitra and Brucker 2017). The
poverty rate for blacks was 22% in 2016, compared with 19% for Hispanics, 9% for non-

9

Hispanic whites and 10% for Asians (Siegel, Miller et al. 2017). About 37% of the
socioeconomic disparity in CRC incidence is attributable to a higher prevalence of
behavioral risk factors, such as obesity, unhealthy dietary patterns, physical inactivity,
and smoking (Doubeni, Major et al. 2012); while more than 40% of the racial disparity in
CRC incidence can be explained by differences in screening uptake (Lansdorp-Vogelaar,
Kuntz et al. 2012). The greater mortality disparity can be explained by inequities in
comorbidities, access to care and treatment (Coughlin, Blumenthal et al. 2016), and
deferred follow-up of screening-detected abnormalities (Laiyemo, Doubeni et al. 2010,
Partin, Gravely et al. 2017).

Table 2.1 Colorectal Cancer Incidence (2009-2013) and Mortality (2010-2014) Rates by
Race, Ethnicity and Sex.
Incidence

Mortality

40.7

14.8

Overall
Men

Women

Men

Women

All persons

46.9

35.6

17.7

12.4

Non-Hispanic white

46.1

35.2

17.3

12.3

Non-Hispanic black

58.3

42.7

25.9

16.9

Hispanic

42.8

29.8

15.0

9.2

Asian Americans and Pacific Islanders

37.8

27.8

12.4

8.8

Native Americans and Native Alaskans

51.4

41.2

19.5

14.0

Note: Rate per 100,000 population
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2.2 Colorectal Cancer Screening
Most cases of CRC occur in average-risk adults. Increasing age, male sex, and
non-Hispanic black race are associated with increased CRC incidence (Siegel, Miller et
al. 2017). Early detection of CRC through routine screening has been demonstrated to be
effective in reducing the incidence of and mortality from this disease (Whitlock, Lin et al.
2008, Koretz 2016). The USPSTF strongly recommends screening for CRC beginning at
the age of 50 and continuing until the age of 75 for individuals at average risk, indicating
that there is high degree of certainty in the net benefit of screening for CRC (Whitlock,
Lin et al. 2008, US Preventive Services Task Force 2016). Individuals who are at
increased or high risk are generally recommended to receive colonoscopies and should
begin receiving screenings earlier than the general population (Wong, Wong et al. 2015).
The decision to screen for CRC in individuals aged 76 to 85 years should be an individual
one, based on professional judgment and patient preference (US Preventive Services
Task Force 2016). In this document, we will focus on average-risk individuals: those who
are asymptomatic and who have no personal or family history of colorectal cancer
(Lieberman, Ladabaum et al. 2016).
There are a number of screening tests available to detect early-stage CRC and
prevent incident cases, including 1) flexible sigmoidoscopy every 5 years, 2) FIT-DNA
every 1 or 3 years, 3) fecal occult blood test or fecal immunochemical testing every year,
4) CT colonography every 5 years, 5) flexible sigmoidoscopy every 10 years plus FIT
every year, and 6) and colonoscopy every 10 years (US Preventive Services Task Force
2016). The USPSTF provided evidence that screening for CRC in adults aged 50 to 75
years reduces CRC mortality even though the various screening tests have differing levels
11

of evidence to support their effectiveness, as well as distinct strengths and limitations (US
Preventive Services Task Force 2016). When compared with no screening, all CRC
screening strategies are cost-effective, though there is disagreement as to which screening
strategy is the most cost-effective (Patel and Kilgore 2015). The screening tests listed
above are not presented in any preferred or ranked order; instead, the purpose of
recommending them is to maximize the total number of people who are screened, which
will have the greatest effect on reducing CRC mortality (Ransohoff and Pignone 2013,
US Preventive Services Task Force 2016). The USPSTF recommends screening via any
of the accepted methods, as any method of screening is better than no screening at all (US
Preventive Services Task Force 2016).

Table 2.2 USPSTF Recommended Colorectal Cancer Screening Strategies
Screening Method

Screening Interval

Stool-Based Tests
Guaiac-based fecal occult blood
test (gFOBT)

Every year

Fecal immunochemical test (FIT)

Every year

FIT-DNA

Every 1 or 3 years

Direct Visualization/ Structural Exams
Colonoscopy

Every 10 years

CT colonography

Every 5 years

Flexible sigmoidoscopy

Every 5 years

Flexible sigmoidoscopy with FIT

Flexible sigmoidoscopy every 10 years plus
FIT every year
12

The USPSTF derived several estimates from modeling conducted by the Cancer
Intervention and Surveillance Modeling Network (CISNET) and presented the estimated
number of life years gained, CRC deaths averted, lifetime colonoscopies required, and
resulting complications per 1,000 screened adults aged 50 to 75 years for each of the
screening strategies (Knudsen, Zauber et al. 2016, US Preventive Services Task Force
2016). Across the different screening methods, colonoscopy showed the highest number
of years gained and CRC deaths averted per 1,000 screened adults aged 50 to 75. On the
other hand, colonoscopy had the highest lifetime colonoscopies required and the highest
number of complications (gastrointestinal and cardiovascular events) of CRC screening
and follow-up testing per 1,000 screened adults aged 50 to 75 (Knudsen, Zauber et al.
2016, US Preventive Services Task Force 2016). Gastrointestinal events involve
perforations, bleeding, transfusions, paralytic ileus, nausea and vomiting, dehydration,
and abdominal pain (van Hees, Zauber et al. 2014, Knudsen, Zauber et al. 2016).
Cardiovascular events include myocardial infarction, angina, arrhythmia, congestive
heart failure, cardiac or respiratory arrest, syncope, hypotension, and shock (van Hees,
Zauber et al. 2014, Knudsen, Zauber et al. 2016, US Preventive Services Task Force
2016). A previous study has examined the differential harms of colonoscopy by age
group and found increasing rates of serious adverse events from colonoscopy with
increasing age (Lin, Piper et al. 2016).
The benefits and risks of different screening options vary (Knudsen, Zauber et al.
2016, US Preventive Services Task Force 2016), but from a clinical perspective,
colonoscopy is the preferred screening method, because a colonoscopy allows doctors to
13

examine the entire length of the colon and remove all cancers and precancerous polyps
during the same procedure (Levin, Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf,
Basch et al. 2016, Benard, Barkun et al. 2018, Duarte, Bernardo et al. 2018).
Colonoscopy is also recommended as a follow-up when another CRC screening is
positive. Moreover, colonoscopy is validated in a randomized trial as having a mortality
benefit (Patel and Kilgore 2015, Koretz 2016, US Preventive Services Task Force 2016).
A colonoscopy remains the most commonly recommended test since it has the
ability to detect polyps throughout the entire colon lumen (Wolf, Basch et al. 2016). It
also has the advantage of not needing to be repeated for 10 years (US Preventive Services
Task Force 2016). However, patients must meet several requirements before receiving a
colonoscopy, such as bowel preparation, a facility visit, and a pre-procedure specialty
office visit (Cheng, Huang et al. 2017). An adequate bowel preparation is needed in order
for the doctors to view the colon clearly. Inadequate bowl preparation has been shown to
decrease the adenoma detection rate (Sherer, Imler et al. 2012, Brimhall, Hankins et al.
2016). It requires taking medication that causes diarrhea to empty the colon (Cheng,
Huang et al. 2017). Furthermore, sedation is designed to depress an individual’s level of
consciousness and to provide anxiolysis, amnesia, and analgesia. Therefore, colonoscopy
requiring a day away from work and a chaperone to provide transportation (Wolf,
Fontham et al. 2018). Polyps can be removed by passing a wire loop through the
colonoscope either to cut the polyp from the wall of the colon, or demolish it in place
using an electric current (Levin, Lieberman et al. 2008). Use of flexible sigmoidoscopy
and fecal occult blood test have considerably declined in the past two decades in favor of
colonoscopies (Phillips, Liang et al. 2007, Fenton, Cai et al. 2008, Schenck, Peacock et
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al. 2009, Klabunde, Cronin et al. 2011), a fact which may be partly attributed to growing
reimbursement for average-risk colonoscopies, physician preferences and referral
patterns (Harewood and Lieberman 2004, Ransohoff 2005, Duarte, Bernardo et al. 2018).
In 2012, 62% of all adults aged 50 to 75 who were screened for CRC received a
colonoscopy versus other modalities, with fecal occult blood test coming in second at
10% (Centers for Disease Control and Prevention 2013). However, colonoscopies miss
around 10% of significant lesions in expert setting and are more costly on a one-time
basis than any other screening test (Meester, Doubeni et al. 2015). In addition, many
individuals do not want an invasive test or a test that requires bowel preparation
(Inadomi, Vijan et al. 2012, Cheng, Huang et al. 2017). Moreover, colonoscopies involve
a wider variation in quality and higher potential for patient injury than any other
screening test (Rembacken, Hassan et al. 2012, Pinto-Pais 2017, Rex and Ponugoti 2017).
Finally, access may be limited by insurance status and local resources (Joseph, Meester et
al. 2016). Therefore, providers should consider patient preference and test availability
when making CRC screening recommendations and offering choices. Shared decision
making can also improve adherence (Inadomi, Vijan et al. 2012, Wolf, Fontham et al.
2018).
Flexible sigmoidoscopy is an endoscopic procedure that examines the lower half
of the colorectal lumen. A simple bowel preparation is needed before the examination
(Wolf, Fontham et al. 2018). If a pre-cancerous adenoma or colorectal cancer is found, a
follow-up colonoscopy will be required to examine the entire colon (Niedermaier, Weigl
et al. 2018). Flexible sigmoidoscopy is usually performed without sedation, thus
requiring less time commitment than colonoscopy (Wolf, Fontham et al. 2018). Previous
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RCTs have demonstrated that a single flexible sigmoidoscopy is a safe, well accepted,
and effective screening method for the prevention of CRC (Atkin, Edwards et al. 2010,
Segnan, Armaroli et al. 2011, Holme, Loberg et al. 2014, Atkin, Wooldrage et al. 2017).
A recent 17-year follow-up of the UK Flexible Sigmoidoscopy Screening Trial reported a
26% reduction in the incidence of CRC and a 30% reduction in mortality (Atkin,
Wooldrage et al. 2017).
CT colonography has been recommended by the American Cancer Society since
2008 and was added to the USPSTF guideline in 2016 (US Preventive Services Task
Force 2016, Wolf, Fontham et al. 2018). CT colonography involves the acquisition of
thin-slice computed tomography images that can be evaluated as two-dimensional images
or reconstructed into three-dimensional images of the colorectal lumen (Wolf, Fontham et
al. 2018). Bowel preparation is needed before the examination and follow-up
colonoscopy is required to remove any abnormalities detected (Wolf, Fontham et al.
2018). According to a systematic review and meta-analysis study conducted by Lin and
colleagues (2012), patients preferred CT colonography over colonoscopy. Limited bowel
preparations for CT colonography may be the reason for this preference (Lin, Kozarek et
al. 2012). Several studies reported that CRC detection rates with CT colonography were
essentially identical to those achieved with colonoscopy (Pickhardt, Choi et al. 2003,
Johnson, Chen et al. 2008). However, a systematic review of detection rates for advanced
colorectal neoplasia (ACN) among asymptomatic patients showed that 6% of patients
who received a CT colonography were diagnosed with cancer, while 9% who received a
colonoscopy were diagnosed with cancer (Duarte, Bernardo et al. 2018). Duarte and
colleagues concluded that CT colonography is an option for CRC screening in
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asymptomatic patients, but because CT colonography is inferior in detecting ACN, it
should not replace colonoscopy (Duarte, Bernardo et al. 2018).
Stool-based tests examine the stool for secondary signs of cancer such as bleeding
or shedding of cells and are less invasive and less expensive than other options
(Lieberman, Ladabaum et al. 2016). Stool-based tests do not require a bowel preparation.
They can be completed in the privacy of the patient’s home and do not require time off
from work (Wolf, Fontham et al. 2018). However, Modeling studies suggest that the
number of years of life saved through a high-quality stool-based screening strategy are
similar to the outcomes of a high-quality colonoscopy screening strategy (Knudsen,
Zauber et al. 2016, US Preventive Services Task Force 2016). The fecal occult blood test
averted 22 CRC deaths per 1,000 screened adults aged 50 to 75, and the fecal
immunochemical test averted 22 CRC deaths per 1,000 screened adults aged 50 to 75.
During the same time period, Colonoscopy averted 24 CRC deaths per 1,000 screened
adults aged 50 to 75 (Knudsen, Zauber et al. 2016, US Preventive Services Task Force
2016). All positive stool-based tests must be followed up with colonoscopy (Partin,
Gravely et al. 2017, May, Yano et al. 2018).
FIT-DNA is a new test with limited data on screening outcomes (Lieberman,
Ladabaum et al. 2016). FIT-DNA combines tests for stool DNA markers associated with
cancer and adenomas with a FIT with published performance characteristics (Wolf,
Fontham et al. 2018). This test can be done in the privacy of the patient’s home and does
not require time off work (Wolf, Fontham et al. 2018). Only one such test (called
Cologuard) is currently available in the United States. It was approved by the U.S. Food
and Drug Administration (FDA) in 2014 for screening men and women aged 50 or older
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who have an average risk of CRC. Effective October 9, 2014, Medicare covered the stool
DNA test with no co-insurance or Part B deductible for Medicare beneficiaries who are
aged 50 to 85 and who have no symptoms of CRC or are at increased risk of CRC. FITDNA testing is covered by Medicare at three-year intervals, as it is considered an
acceptable testing modality by USPSTF (US Preventive Services Task Force 2016).
According to a large, manufacturer-funded, multicenter, comparative trial of DNA and
FIT testing in average-risk individuals, the sensitivity of DNA testing for detecting
colorectal cancer was 92%, and the sensitivity of FIT was 74%. The sensitivity for
detecting advanced precancerous lesions was 42% with DNA testing and 24% with FIT.
Moreover, specificities with DNA testing and FIT were 87% and 95%, respectively
(Imperiale, Ransohoff et al. 2014). FIT-DNA is included in the American Cancer Society
and USPSTF guidelines (US Preventive Services Task Force 2016, Wolf, Fontham et al.
2018). All positive tests must be evaluated by colonoscopy (Wolf, Fontham et al. 2018).
The mortality rate from CRC has been decreasing steadily since 1980 (Weir,
Thompson et al. 2015, Siegel, Miller et al. 2017), a fact which partially may be
attributable to removal of pre-cancerous, adenomatous polyps at an early stage based on
diagnosis of CRC and widespread use of colonoscopy or other screening approaches
(Cunningham, Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin,
Tully et al. 2017, Partin, Gravely et al. 2017). Nonetheless, self-reported CRC screening
rates from the National Health Interview Survey are at 58%, and the National Committee
for Quality Assurance (NCQA) indicates that only 60% of commercial and 69% of
Medicare plan members aged 50 to 75 years received an appropriate CRC screening in
2016 (Paskett and Khuri 2015, White, Thompson et al. 2017). Moreover, BRFSS data
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indicate that around 65% of adults aged 50 to 75 years reported having had one of the
colorectal screening tests recommended by USPSTF, and around 60% of adults aged 50
to 75 years had received a colonoscopy within the past 10 years (Joseph, King et al. 2012,
Liss and Baker 2014).

Table 2.3 Percentage of adults who received colorectal cancer screenings according to the
recommended schedule, by selected sociodemographic characteristics and health care
access – National Health Interview Survey, United States, 2015
Characteristics
N
%
Overall
12,650
62.4
Age group (years)
50-64
7,947
57.9
65-75
4,703
71.8
Race
White
10,051
63.7
Black
1,777
59.3
American Indian/Alaska Native
160
48.4
Asian
595
52.1
Ethnicity
Non-Hispanic
11,163
64.2
Hispanic
1,487
47.4
Education
Less than high school
1,681
46.7
High school graduate/GED
3,275
58.2
Some college/Associate degree
3,896
63.5
College graduate
3,754
70.7
Percentage of federal poverty threshold
<139
2,702
46.9
139-250
2,432
56.1
250-400
2,455
62.6
>400
5,060
70.0
Health care coverage
Private
7,628
65.6
Military
702
77.6
Public only
3,494
60.1
Uninsured
790
25.1
Note: Results for individuals aged 50-75 years who received a fecal occult blood test
within 1 year, a sigmoidoscopy within 5 years and fecal occult blood test within 3 years,
or a colonoscopy within 10 years
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In 2010, the US Department of Health and Human Services (HHS) initiated
HP2020, which covered several objectives for reducing cancer mortality. Each objective
was assigned a baseline measure in 2007 and a target to be achieved by 2020. HP2020
calls for a 15% reduction in death rates from 2007 to 2020 for CRC (Weir, Thompson et
al. 2015). Moreover, the National Colorectal Cancer Roundtable (NCCRT) initiated a
goal to increase the CRC screening rate to 80% in the eligible population by 2018
(Karlitz, Oliphant et al. 2017). Achieving this goal would avert 280,000 new cases of
CRC and 200,000 deaths from the disease by 2030, and 24.4 million people would be
screened (Fedewa, Ma et al. 2015, Meester, Doubeni et al. 2015). Nonetheless, the
aforementioned screening rates are lower than the use of preventive interventions for
other screening-amenable cancers, below the 80% coverage of the CRC screening target,
and below the HP2020 target of 71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al.
2017, White, Thompson et al. 2017).
Previous studies have identified numerous barriers facing individuals who wish to
receive CRC screenings, including barriers at the patient, provider, and health care
system levels (McLachlan, Clements et al. 2012, Ramdass, Petraro et al. 2014, Bromley,
May et al. 2015, Wang, Qiu et al. 2018).
These barriers include low educational attainment and literacy, gender (female),
race (Hispanic or non-Hispanic black), embarrassment or fear concerning the procedure,
concerns about the cost, comorbidities, and lack of health insurance (Meissner, Klabunde
et al. 2012, Weiss, Smith et al. 2013, Hughes, Watanabe-Galloway et al. 2015, Knight,
Kanotra et al. 2015, Zhao, Okoro et al. 2018). Meanwhile, having a higher income, being
married, being at the upper end of the age-range screening guidelines, having a usual
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source of care, and having an increased perceived risk of CRC are associated with
increased CRC screening rates (Palmer, Midgette et al. 2010, James, Daley et al. 2011,
Winterich, Quandt et al. 2011, Meissner, Klabunde et al. 2012, Wilkins, Gillies et al.
2012, Ruggieri, Bass et al. 2013, Ramdass, Petraro et al. 2014). Racial and ethnic
disparities in CRC screening have been documented broadly; and most studies indicate a
lower rate of screening among racial and ethnic minorities (Shih, Zhao et al. 2006,
Burnett-Hartman, Mehta et al. 2016, Hong, Tauscher et al. 2017). Hong and colleagues
(2017) also reported racial and ethnic disparities in CRC screening among Hispanics and
Asian Americans (Hong, Tauscher et al. 2017). The Centers for Disease Control and
Prevention (CDC) reported that racial and ethnic minorities were significantly less likely
to receive colonoscopies within the recommended 10-year guidelines than non-Hispanic
whites (Centers for Disease Control and Prevention 2013).
Being at the upper end of the age-range screening guidelines was associated with
higher rates of CRC screening (Seeff, Nadel et al. 2004, Ellison, Jandorf et al. 2011,
Centers for Disease Control and Prevention 2013, Ramdass, Petraro et al. 2014, White,
Thompson et al. 2017). White and colleagues (2017) reported that individuals aged 65 to
75 years were significantly more likely to receive CRC screening than individuals aged
50 to 64 years (White, Thompson et al. 2017). Ellison and colleagues (2011) found that
individuals aged 65 years or older were 2.17 times more likely to be receive CRC
screening than individuals aged 50 to 64 years (Ellison, Jandorf et al. 2011). Ramdass
and colleagues (2014) found that individuals aged 61 to 70 years and 71 to 80 years were
significantly more likely to have received a screening colonoscopy in the past 10 years
than individuals aged 50 to 60 years (Ramdass, Petraro et al. 2014). The CDC (2013)
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reported that individuals aged 65 to 75 years were significantly more likely to have
received a colonoscopy within the past 10 years than individuals aged 50 to 64 years
(Centers for Disease Control and Prevention 2013). Seeff and colleagues (2004) found
that individuals aged 60 to 69 were 1.87 times more likely to have received an endoscopy
within the past 10 years than individuals aged 50 to 59 years, and individuals aged 70
to79 years were 2.12 times more likely to have received an endoscopy than those aged 50
to 59 years (Seeff, Nadel et al. 2004).
Marital status was associated with higher rates of CRC screening (Seeff, Nadel et
al. 2004, Ellison, Jandorf et al. 2011, Grzywacz, Hussain et al. 2017). Ellison and
colleagues (2011) found that married participants were 2.09 times more likely to receive
CRC screenings than unmarried participants (Ellison, Jandorf et al. 2011). Wilcox and
colleagues found that single participants were 0.65 times less likely to have a
colonoscopy than other participants (Wilcox, Acuna et al. 2015). Seeff and colleagues
(2004) found that unmarried participants were 0.86 times less likely to have received an
endoscopy within the past 10 years than married participants (Seeff, Nadel et al. 2004).
There are also gender differences in CRC screening rates (Seeff, Nadel et al.
2004, Partin, Gravely et al. 2016). Men are significantly more likely to visit endoscopy
clinics than women. Partine and colleagues (2016) found that women are less likely to
have had an colonoscopy screening than men (Partin, Gravely et al. 2016). Ramdass and
colleagues (2014) found that men were 2.71 times more likely than women to have had a
screening colonoscopy in the past 10 years (Ramdass, Petraro et al. 2014). Seeff and
colleagues (2004) found that women were 0.58 times less likely than men to have
received an endoscopy within the past 10 years (Seeff, Nadel et al. 2004).
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Individuals with lower household incomes and less education are less likely to
have had a CRC screening (Courtney, Paul et al. 2013, Fedewa, Ma et al. 2015, Meyer,
Allard et al. 2016, White, Thompson et al. 2017). Previous studies found a strong
association between colonoscopy use and income, with higher income groups being
associated with higher rates of colonoscopy use (Benarroch-Gampel, Sheffield et al.
2012, Centers for Disease Control and Prevention 2013, Solbak, Xu et al. 2018).
Grzywach and colleagues (2017) found that individuals with lower income levels were
less likely to have a sigmoidoscopy or colonoscopy than individuals with higher income
levels (Grzywacz, Hussain et al. 2017).
Health insurance coverage is associated with CRC screening. Zhao and colleagues
(2018) found that compared with persons who are adequately insured, those who are
underinsured who were uninsured are less likely to receive CRC screening (Zhao, Okoro
et al. 2018). White and colleague (2017) found that persons having any type of health
insurance were more likely to receive CRC screening than those who had no insurance at
all (White, Thompson et al. 2017). Individuals having health insurance were more likely
to have received a colonoscopy within the past 10 years than those who had no health
insurance (Centers for Disease Control and Prevention 2013). Individuals having private
health insurance were 1.84 times more likely to receive colonoscopy screening than those
without private health insurance (Courtney, Paul et al. 2013).
Residence location is associated with CRC screening (Meyer, Allard et al. 2016,
Partin, Gravely et al. 2016, Wang, Qiu et al. 2018). People who live in rural or suburban
settings are significantly less likely to receive CRC screening than people who live in city
centers. More specifically, rural residents are 0.85 times less likely to receive CRC
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screenings than urban residents (Meyer, Allard et al. 2016). Partin and colleagues (2016)
showed that people who live in urban areas were 1.13 times more likely to miss
colonoscopy than people who live in rural or highly rural areas (Partin, Gravely et al.
2016). Shih and colleague (2006) reported that people who live in the West were 1.24
times more like to have CRC screenings than people who live in the Northeast (Shih,
Zhao et al. 2006).
Healthy lifestyles, including having other screening tests, exercising, eating large
amounts of fruits and vegetables, and not smoking, were associated with higher rates of
CRC screening (Seeff, Nadel et al. 2004, Sewitch, Fournier et al. 2007, Ellison, Jandorf
et al. 2011, Grzywacz, Hussain et al. 2017). Ellison and colleagues (2011) found that
individuals who had regular mammograms were 2.38 times more likely to receive CRC
screening than those who did not (Ellison, Jandorf et al. 2011). Sewitch and colleagues
(2007) found that individuals who received regular flu shots were 1.51 times more likely
to receive endoscopies than those who did not (Sewitch, Fournier et al. 2007).
There was extensive evidence to support the impact of primary prevention
strategies, primarily through lifestyle modification (Tarraga Lopez, Albero et al. 2014).
Previous studies have indicated that avoidance of smoking and alcohol consumption,
maintaining a healthy weight, and moderate physical activity are associated with
markedly lower risks of CRC (Chan and Giovannucci 2010, Gong, Hutter et al. 2012,
Crosara Teixeira, Braghiroli et al. 2014, Gong, Hutter et al. 2016). To achieve a
significant reduction in CRC incidence, primary prevention is crucial complement to
CRC screening. Smokers have an increased risk of receiving a diagnosis of an adenoma
and higher risk of CRC-related death associated with current smoking (Gong, Hutter et
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al. 2012, Tarraga Lopez, Albero et al. 2014). Previous studies found that individuals who
engaged in any amount of vigorous activity were at lower risk of developing CRC than
those who did not engage in this activity and regular physical activity cuts the risk of
CRC by round 40% (Tarraga Lopez, Albero et al. 2014, Nunez, Nair-Shalliker et al.
2018).
These healthy lifestyles were also associated with higher rates of CRC screening
(Seeff, Nadel et al. 2004, Sewitch, Fournier et al. 2007, Ellison, Jandorf et al. 2011,
Grzywacz, Hussain et al. 2017). Individuals with moderate physical activity were 1.25
times more likely to have received an endoscopy within the past 10 years than those who
had no significant physical activity (Seeff, Nadel et al. 2004). In addition, people who
had exercised within the past 30 days were 1.25 times more likely to have had a
sigmoidoscopy or colonoscopy than those who did not exercise (Grzywacz, Hussain et al.
2017).
With regard to healthy lifestyle habits, smoking status deserves particular
attention. Sewitch and colleagues (2007) found that former smokers were 1.20 times
more likely, and those who had never smoked were 0.84 times less likely to have
received an endoscopy in the past 10 years than current smokers (Sewitch, Fournier et al.
2007). On the other hand, Seeff and colleagues (2004) found that current smokers were
0.82 times less likely to have received an endoscopy within the past 10 years than those
who had never smoked. Meanwhile, Grzywach and colleagues (2017) found that current
smokers were more likely to have had a sigmoidoscopy or colonoscopy than those who
had never smoked (Grzywacz, Hussain et al. 2017).
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The absence or presence of comorbidities is associated with CRC screening
(Grzywacz, Hussain et al. 2017, Wang, Qiu et al. 2018). Grzywach and colleagues (2017)
found that individuals with diabetes were 1.45 times more likely to have a sigmoidoscopy
or colonoscopy than those without diabetes, and individuals with an activity limitation
were 1.33 times more likely to have a sigmoidoscopy or colonoscopy than those with no
limitation (Grzywacz, Hussain et al. 2017). Partin and colleagues (2017) found that
individuals with low Charlson comorbidity scores were more likely to have
colonoscopies than those with higher scores. More specifically, individuals with zero
Charlson scores were 1.23 times more likely to have colonoscopies than individuals with
Charlson scores ≥ 3 (Partin, Gravely et al. 2017). Wang and colleagues (2018) discovered
that people who had chronic conditions were more likely to be up-to-date on CRC
screenings than those who did not have chronic conditions (Wang, Qiu et al. 2018).
Moreover, a perceived low or moderate CRC risk significantly increased a person’s odds
of being screened by colonoscopy when compared to those who had no unusual risk for
CRC (Ramdass, Petraro et al. 2014). López-Charneco and colleagues (2013) found that
individuals with perceived fair to poor health status were 1.17 times more likely to
receive a sigmoidoscopy or colonoscopy within 5 years than individuals with perceived
good to excellent health status (Lopez-Charneco, Perez et al. 2013).
Provider-level barriers to CRC screening included physician’s gender, specialty,
years in practice, lack of provider recommendation, lack of provider recognition of
barriers, and lack of a regular provider (Holt, Shipp et al. 2009, James, Daley et al. 2011,
Ruggieri, Bass et al. 2013, Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016).
One of the most powerful factors in increasing adherence to CRC screening is provider
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recommendation (Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016). A
systematic review showed that provider recommendation significantly improves
screening rates (Peterson, Ostroff et al. 2016). Furthermore, it has been found that
offering patients a choice of CRC screening through shared decision making, rather than
recommending a single test, can improve adherence to screening (Inadomi, Vijan et al.
2012, Wolf, Fontham et al. 2018). Ramdass and colleagues (2014) found that provider
recommendation for a colonoscopy is the most effective strategy in promoting screening
colonoscopies in the US (Ramdass, Petraro et al. 2014). In order for their screening
recommendations to be figured into the NCCRT target rate of 80% and the HP2020 target
of 71%, providers must recommend CRC screenings to all eligible individuals and
provide follow-up to ensure their recommendations are followed. This is easier in some
practice settings than others; for instance, large integrated health systems have systems in
place to remind physicians and provide follow-up for recommendations (Potter, Ackerson
et al. 2013). Thus system-level interventions could promote achieving the target 80%
coverage of CRC screening and the HP2020 target of 71%. Moreover, outreach strategies
whereby patients receive invitations to CRC screening via mail have demonstrated an
increase in CRC adherence rates (Kempe, Shetterly et al. 2012, Gupta, Halm et al. 2013,
Singal, Gupta et al. 2016).
Individuals having a regular physician or usual source of care were significantly
more likely to receive CRC screening than those who did not (Ellison, Jandorf et al.
2011, Centers for Disease Control and Prevention 2013, Grzywacz, Hussain et al. 2017,
White, Thompson et al. 2017). White and colleagues (2017) found that individuals
having a regular provider were significantly more likely to receive CRC screening than
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individuals who did not (White, Thompson et al. 2017). Ellison and colleagues (2011)
found that individuals having a regular physician were significantly more likely to be
CRC screening-adherent (Ellison, Jandorf et al. 2011). Grzywach and colleagues (2017)
found that individuals having a personal doctor and health care provider were more likely
to have a sigmoidoscopy or colonoscopy than those who did not (Grzywacz, Hussain et
al. 2017). Seeff and colleagues (2004) found that individuals having a usual source of
care were 1.77 times more likely to have received an endoscopy within the past 10 years
than those who did not (Seeff, Nadel et al. 2004). The CDC reported that individuals
having a regular provider were significantly more likely to have received a colonoscopy
within the past 10 years than individuals who did not (Centers for Disease Control and
Prevention 2013).
A few studies have found that female patients have a preference for female
gastroenterologists for office visits and colonoscopies (Menees, Inadomi et al. 2005,
Shah, Karasek et al. 2011, Chong 2012). The main reason for this sex preference was
embarrassment, and a higher level of education was a significant factor in producing
higher levels of patient embarrassment. Shah and colleagues (2011) confirmed that more
than 30% of female patients would avoid receiving a colonoscopy if they were unable to
have a physician of their sex preference (Shah, Karasek et al. 2011). Menees and
colleagues (2011) also confirmed that 43% of female patients expressed preference for
female colonoscopists; and of these, 87% would be willing to wait more than 30 days in
order to access a female colonoscopist (Menees, Inadomi et al. 2005). Therefore,
accommodating patient sex preference may improve adherence to CRC screening
recommendations.
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System-level barriers to CRC screening included the out-of-pocket cost, capacity,
high numbers of uninsured, fewer specialist referrals, fewer interactions with a primary
care physician (Palmer, Midgette et al. 2008, Holt, Shipp et al. 2009, Hatcher, Dignan et
al. 2011, Lukin, Jandorf et al. 2012, Wilkins, Gillies et al. 2012, Joseph, Meester et al.
2016). A recent study reported that the estimated colonoscopy capacity was sufficient to
screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016). However,
colonoscopies vary by quality, and high-quality colonoscopies take considerably more
time than the average time physicians spend on colonoscopies (Vicari 2010, Keswani,
Yadlapati et al. 2015, Bitar, Zia et al. 2018). Previous studies have demonstrated that
physician supply has been associated with increased use of colonoscopy (Brouse, Wolf et
al. 2008, Haas, Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth,
Josey et al. 2017). Benarroch-Gampel and colleagues (2012) examined the influence of
colonoscopist and primary care physician supply on racial disparities in receipt of
colonoscopy and found that while increasing colonoscopist and primary care physician
capacity was associated with increased colonoscopy use in whites, but it was associated
with decrease in colonoscopy use in blacks and Hispanics (Benarroch-Gampel, Sheffield
et al. 2012). An increased supply of providers may have little beneficial effect on race
and ethnic disparities in the receipt of colonoscopies or on geographic disparities in the
receipt of colonoscopies (Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al.
2017). Interventions should focus on improving screening in populations living in rural
areas and among minorities. If gastroenterologists are in short supply, alternatives may be
considered in the short-run like training primary care providers to conduct colonoscopies
(Selby, Cornuz et al. 2016).
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Out-of-pocket costs may dampen patients’ willingness to undergo CRC screening;
and this is especially true for colonoscopies, which usually involve relatively high-cost
sharing (Klabunde, Riley et al. 2004, Hamman and Kapinos 2015). In some areas,
however, charges for the same services can differ more than tenfold, varying from
roughly $500 to more than $8,000 (Lieberman and Allen 2015, Robinson, Brown et al.
2015). Pyenson and colleagues (2014) determined the costs related with colonoscopy in
the commercial and Medicare populations and confirmed that the average allowed
amount for a screening colonoscopy was $2,146 in the commercial population and $1,071
in the Medicare population, with average cost sharing of $334 the commercial population
and $275 in the Medicare population (Pyenson, Scammell et al. 2014). Previous studies
have shown that cost-sharing reduces preventative health care use, including the use of
highly effective screening tests (Busch, Barry et al. 2006, Goodwin and Anderson 2012).
One study examined the impact of eliminating coinsurance for colonoscopy and found
that waiving coinsurance for colonoscopies resulted in an 18% increase in screening
(Khatami, Xuan et al. 2012).
Beginning in September 2010, the ACA required all non-grandfathered private
health plans to offer coverage of CRC screenings without cost-sharing to address the
negative consequences of financial barriers on the use of preventative services and to
promote CRC screening. Consistent with the ACA policy requirement, beginning January
1, 2011, Medicare waived Part B deductibles for all colonoscopies and eliminated
coinsurance for screening colonoscopies, though not for therapeutic ones (Howard, Guy
et al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face
unexpected out-of-pocket liabilities when a polyp is detected and removed during a
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colonoscopy, in which case patients are billed a copay if diagnostic colonoscopy.
Medicare beneficiaries are also responsible for Part B deductible and coinsurance when a
colonoscopy is performed as part of a two-step screening process after another CRC
screening is positive (Howard, Guy et al. 2014). This loophole may discourage the use of
screening, so eliminating remaining loopholes for Medicare beneficiaries could improve
screening rates.
The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R.
1017/S. 479), sponsored by US Representatives Charlie Dent and Donald Payne, Jr., in
the House of Representatives and Senator Sherrod Brown in the Senate, works to correct
an oversight in current law that requires Medicare beneﬁciaries to cover the cost of their
copayment for a free screening colonoscopy if a polyp is discovered and removed during
the procedure (Howard, Guy et al. 2014, Hamman and Kapinos 2015). Under current law,
Medicare waives coinsurance and deductibles for colonoscopies. However, when a polyp
is discovered and removed, the procedure is reclassiﬁed as therapeutic for Medicare
billing purposes and beneficiaries become responsible for paying 20% coinsurance
(Hamman and Kapinos 2015). This bill would eliminate costs for Medicare beneﬁciaries
when a polyp is discovered and removed, ensuring that unexpected copays do not deter a
patient from receiving screening (Howard, Guy et al. 2014). By eliminating ﬁnancial
barriers, this legislation would attain higher screening rates and reduce the incidence of
and mortality from CRC. This bill received 277 combined co-sponsors in the 115th
Congress.
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2.3 Medicare Coverage of Colorectal Cancer Screening
Medicare is the federal health insurance program for people who are 65 or older
(Altman and Frist 2015, Huffman and Upchurch 2018). It also covers younger adults with
permanent disabilities and End-Stage Renal Disease. Medicare Part A (Hospital
Insurance) covers inpatient hospital stays, care in a skilled nursing facility, hospice care,
and some home care. Medicare Part B (Medical Insurance) covers doctor’s services,
outpatient care, medical supplies, and preventive services. Medicare Part C (Medicare
Advantage Plans) is a type of Medicare health plan offered by a private company that
contracts with Medicare. Medicare Part C provides all the benefits of Part A and Part B.
Medicare Part D provides prescription drug coverage (Altman and Frist 2015).
Medicaid is a joint federal and state health insurance program providing needbased insurance to low-income children and adults, and many people are eligible for both
Medicare and Medicaid. Roughly 10 million individuals are “dual eligible” for Medicare
and Medicaid (Altman and Frist 2015).
Medicare is the largest payer for health care services in the United States and
covers many preventive services, including colorectal cancer screening (Altman and Frist
2015). Today, Medicare Part B covers several types of CRC screening tests, including
barium enema, colonoscopy, fecal occult blood test, multi-target stool DNA test, and
flexible sigmoidoscopy (Howard, Guy et al. 2014). The Centers for Medicare and
Medicaid Services (CMS) pays 100% of the charge for fecal occult blood tests, flexible
sigmoidoscopies, colonoscopies, and multi-target stool DNA tests and 80% of the charge
for barium enemas. However, when Medicare was first enacted in 1965, preventive
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services were excluded (Lesser, Krist et al. 2011). At the time, there was no strong
evidence presented from a randomized controlled trial to show that CRC screening was
effective in reducing CRC incidence and mortality. Therefore, CRC screening was not
reimbursed or widely practiced. However, after three RCTs in the mid-1990s suggested
efficacy, a wide consensus developed.
The USPSTF made a decision to endorse CRC screening in 1996 and Medicare
made a decision to reimburse for its use in 1998 (Ransohoff 2005). In 1998, Medicare
provided for coverage of colorectal cancer screening procedures under Medicare Part B.
Medicare covered (1) annual fecal occult blood tests (FOBTs); (2) flexible
sigmoidoscopy over 4 years; (3) screening colonoscopy every 10 years for persons at
average risk for colorectal cancer, or every two years for persons at high risk for
colorectal cancer; (4) barium enema every 4 years as an alternative to flexible
sigmoidoscopy, or every 2 years as an alternative to colonoscopy for persons at high risk
for colorectal cancer; and (5) other procedures the Secretary finds appropriate based on
consultation with appropriate experts and organizations. Effective January 1, 2004,
Medicare extended the FOBT screening definition to provide for either one guaiac-based
FOBT (gFOBT) or one immunoassay-based FOBT (iFOBT) at a frequency of every 12
months. Prior studies found that CRC screening rates increased after the Medicare
coverage expansions, but screening rates remained below the recommended levels (Ko,
Kreuter et al. 2005, O'Malley, Forrest et al. 2005, Gross, Andersen et al. 2006, Shih,
Zhao et al. 2006, Ananthakrishnan, Schellhase et al. 2007, Fenton, Tancredi et al. 2009,
White, Vernon et al. 2011). The persistently low screening rates, even after
implementation of these policies, have led researchers to conclude that the financial costs
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might not be an important barrier to CRC screening, and that they should advocate for
new approaches (Stimpson, Pagan et al. 2012). However, these expansions in coverage
left gaps; Medicare beneficiaries without supplemental insurance were responsible for up
to 20% of the allowable charges, which may be the reason for the continued underuse of
CRC screening.
On January 1, 2005, Medicare started covering a one-time initial preventive visit,
known as the ‘‘Welcome to Medicare’’ visit (WMV). The preventive services were made
available to new beneﬁciaries within six months of beginning their Part B coverage
(Salloum, Jensen et al. 2013). The WMV provides an opportunity to review Medicare
beneficiaries’ medical history, current health status, and risk factors, as well as to provide
education, counseling, and referrals (Misra, Lloyd et al. 2018). Medicare’s regular costsharing provisions apply to the visit; that is, it is subject to the Medicare annual Part B
deductible ($100) and a standard 20% Medicare copay above that amount. In 2008,
Medicare waived its Part B deductible for colorectal cancer screening, and the screening
was made available to new beneficiaries within 12 months of beginning their Part B
coverage. However, until 2011, a beneficiary was still responsible for standard 20%
Medicare copays (Salloum, Jensen et al. 2013). As a result of the ACA, Medicare waived
its copays for the WMV, making this benefit free starting in 2011. Historically, only 3 –
6% of eligible beneficiaries get a WMV, even after changes extending benefit eligibility
and waiving the annual deductible (Cuenca 2012, Ganguli, Souza et al. 2017). Recently,
Misra and colleagues (2018) examined the impact of the ACA on WMV utilization and
found that annual WMV rates began at 1% in 2005 and increased to 12% in 2016. The
study indicated that the ACA provision was associated with significantly increased
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utilization of WMV among newly enrolled Medicare beneficiaries (Misra, Lloyd et al.
2018).
In 2011, Medicare introduced the annual wellness visit (AWV) to provide an
annual preventive health benefit to all Medicare beneficiaries who have been enrolled in
Medicare Part B for at least 12 months. The AWV is free for beneficiaries and provides a
regular opportunity to review each beneficiary’s medical history, risk factors, and
functional abilities (Ganguli, Souza et al. 2017). Based on current health status and risk
factors, clinicians develop an individualized prevention plan that establishes preventive
screenings and interventions, including colorectal cancer screening (Colburn and
Nothelle 2018). Shen and colleagues (2017) reported that AWV utilization has increased
over time, from 8% in 2011 to 20% in 2015 (Shen, Warnock et al. 2017).
The ACA required all non-grandfathered private health plans to offer coverage of
CRC screenings without cost-sharing to address the negative consequences of financial
barriers on the use of preventative services and to promote CRC screening. Consistent
with the ACA policy requirement, beginning January 1, 2011, Medicare waived Part B
deductibles and coinsurance for Medicare-approved CRC screenings. Moreover,
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for
screening colonoscopies, though not for therapeutic ones (Howard, Guy et al. 2014,
Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face unexpected
out-of-pocket liabilities when a polyp is detected and removed during a colonoscopy, in
which case patients are billed a copay. Medicare beneficiaries are also responsible for
Part B deductible and coinsurance when a colonoscopy is performed as part of a two-step
screening process after another CRC screening is positive (Howard, Guy et al. 2014).
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This loophole may discourage the use of screening, so eliminating remaining loopholes
for Medicare beneficiaries could improve screening rates.

Table 2.4 Key Medicare Policy Changes for Colorectal Cancer Screening
Year
1998

Policy
(1) annual FOBT; (2) flexible
sigmoidoscopy over 4 years; (3)
screening colonoscopy for individuals at
average risk every 10 years, or for
individuals at high risk every 2 years; (4)
barium enema every 4 years
Extended annual immunoassay-based
(iFOBT)
Welcome to Medicare: one-time initial
preventive visit

Who
Part B

Payment
20% copay

Part B

20% copay

New beneficiaries
within 6 months

2008

Extended Welcome to Medicare

2011

Extended Welcome to Medicare

2011

Annual Wellness Visit

2011

New beneficiaries
within 12 months
New beneficiaries
within 12 months
Part B for at least
12 months
Part B

Part B
deductible,
20% copay
20% copay

(1) annual FOBTs; (2) flexible
sigmoidoscopy over 4 years; (3)
screening colonoscopy for individuals at
average risk every 10 years, or for
individuals at high risk every 2 years; (4)
barium enema every 4 years as an
alternative to flexible sigmoidoscopy, or
every 2 years for individuals at high risk;
Extended Multi-target stool DNA test
Part B
for individuals at average risk every 3
years

2004
2005

2014
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Free
Free
Free, but
20% copay
for barium
enema and
therapeutic
colonoscopy

Free

FIT-DNA is a new test and combines tests for stool DNA markers associated with
cancer and adenomas plus a FIT with published performance characteristics (Wolf,
Fontham et al. 2018). It was approved by the FDA in 2014 for screening men and women
aged 50 or older with an average risk of CRC. Effective October 9, 2014, Medicare
covered the stool DNA test with no co-insurance or Part B deductible for Medicare
beneficiaries aged 50 to 85 who do not have symptoms of colorectal cancer or an
increased risk of colorectal cancer. The test is covered by Medicare at three-year
intervals, as it is considered an acceptable testing modality by USPSTF (US Preventive
Services Task Force 2016). According to a large, manufacturer-funded, multicenter,
comparative trial of DNA and FIT testing in average risk individuals, the sensitivity for
detecting colorectal cancer is 92% with DNA testing and 74% with FIT. The sensitivity
for detecting advanced precancerous lesions is 42% with DNA testing and 24% with FIT.
Moreover, specificities with DNA testing and FIT are 87% and 95%, respectively
(Imperiale, Ransohoff et al. 2014).

2.4 Conceptual Framework
Individuals who wish to receive CRC screenings face multiple barriers. Previous
studies have identified the patient, provider, and health care system-level barriers to CRC
screening (McLachlan, Clements et al. 2012, Ramdass, Petraro et al. 2014, Bromley, May
et al. 2015, Wang, Qiu et al. 2018). In this study, we will focus on colonoscopy among
the recommended CRC screening methods. Colonoscopy is the preferred screening
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method, because a colonoscopy allows doctors to examine the entire length of the colon
and remove all cancers and precancerous polyps in the same procedure (Levin,
Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016, Benard, Barkun
et al. 2018). However, one of the most significant barriers to CRC screening is out-ofpocket financial costs (Howard, Guy et al. 2014); and this is especially true for
colonoscopies because of relatively high cost-sharing requirements (Klabunde, Riley et
al. 2004, Hamman and Kapinos 2015). Therefore, it is critically important to know
whether reduction of financial barriers can improve coverage of colonoscopies.
This study intended to identify the effects of cost-sharing reduction on the receipt
of colonoscopies among the elderly as a result of ACA implementation. The analytical
approach adopted for this analysis was the standard demand theory. Demand for
colonoscopies is influenced by many factors. The major purpose of demand analysis for
health care was to determine those factors which, on the average, most affect a person’s
utilization of health services. Demand analysis seek to identify which factors are most
influential in determining how much care people are willing to purchase. Consumers
purchase goods or services for their utility. If the commodity demanded by consumers is
good health, then health can be produced by goods and services purchased in the market.
Demand for medical care is derived from the more basic demand for health (Muurinen
1982).
According to Grossman (1972), the Demand for Health Model extended the
human capital theory by explicitly incorporating health and recognizing that there are
both consumption and investment reasons for investing in health (Grossman 1972). The
basic characteristics of the model are (1) that health is a consumption commodity, so it
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makes the consumer feel better; and (2) that health is an investment commodity, so a state
of health is determined the amount of time available to the consumer of productivity
(Grossman 1972).
Demand for colonoscopies can be explained using a number of factors, such as
price, price of substitutes, age, gender, income, educational attainment, and other factors,
indicating individual preferences and propensity to assume risks (Benarroch-Gampel,
Sheffield et al. 2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et
al. 2013, Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos
2015, Partin, Gravely et al. 2016, Grzywacz, Hussain et al. 2017). Therefore, the demand
function can be written as follows:

Demand for Colonoscopy= f (Price, Price of substitutes, Income, Age groups, Gender,
Educational attainment, supply, Access, Other factors)

The standard demand theory states that, all other factors being equal, as the price
of a good or service increases, demand for the good or service will decrease, and vice
versa. The demand curve shows the relationship between the price of a product or service
and the quantity of the product or service demanded. Price changes in colonoscopies lead
to movements along demand curve (Howard, Guy et al. 2014, Hamman and Kapinos
2015). Henry and colleagues (2007) conducted a cost analysis of colonoscopy using
micro-costing and time-and-motion techniques to determine the total societal cost of
colonoscopies, and they confirmed that the median direct health care cost for a
39

colonoscopy was $379 (Henry, Ness et al. 2007). Pyenson and colleagues investigated
the cost of colonoscopy screening for average-risk individuals receiving Medicare, and
they reported that the 2015 average Medicare colonoscopy screening costs of $1,035
(Pyenson, Pickhardt et al. 2015). Pyenson and colleagues (2014) determined the costs
related with colonoscopy in the commercial and Medicare populations and confirmed that
the average allowed amount for a screening colonoscopy was $2,146 in the commercial
population and $1,071 in the Medicare population, with average cost sharing of $334 the
commercial population and $275 in the Medicare population (Pyenson, Scammell et al.
2014). Consistent with the ACA policy requirement, beginning January 1, 2011,
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for
screening colonoscopies (Howard, Guy et al. 2014, Hamman and Kapinos 2015).
Therefore, demand for colonoscopies is expected to increase with cost-sharing
reductions.
“Substitutes” means other goods or services which satisfy the same wants, or
provide same characteristics, as something else. There are several substitutes that
individuals can utilize instead of colonoscopies. A number of screening tests exist to
detect early-stage CRC and prevent incident cases, including flexible sigmoidoscopy,
FIT-DNA, fecal occult blood tests, fecal immunochemical tests, CT colonography,
flexible sigmoidoscopy plus FIT, and colonoscopies (US Preventive Services Task Force
2016, Wolf, Fontham et al. 2018). The USPSTF recommends screening via an accepted
method because any screening is better than no screening at all (Atkin, Edwards et al.
2010, Quintero, Castells et al. 2012, Patel and Kilgore 2015). Therefore, the price of
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other CRC screening tests can affect demand for colonoscopies. If the price of other CRC
screening tests increase, demand for colonoscopies is expected to increase.
According to the model (see figure 1), individuals inherit a stock of health when
they are born. Health depreciates over time; however, an individual may able to slow this
decline through an investment in health. As we age, our health stock depreciates faster;
that is, the depreciation rate rises from δ0 to δ1 to δD. The result of aging in this model is a
continuously falling optimal level of health stock. Age may also shift the marginal
efficiency of investment (MEI) curve to the left, because the returns from an investment
will last for a shorter period of time. This will reinforce the decrease in investment that
occurs due to increased depreciation. As people’s age advances, they experience an
increase in the rate of illness and in the utilization of health services. The stock of health
can be maintained by investments to sustain health, including use of colonoscopies. Over
the life cycle, individuals will try to offset part of the increased rate of depreciation in
their stock of health by increasing their expenditure on health. Therefore, demand for
colonoscopies is expected to increase with aging. Previous studies have shown that being
in the upper age-range of screening guidelines is associated with higher rates of screening
colonoscopy (Centers for Disease Control and Prevention 2013, Ramdass, Petraro et al.
2014). Ramdass and colleagues (2014) found that individuals aged 61 to 70 years and 71
to 80 years were significantly more likely to have had a screening colonoscopy within the
past 10 years when compared to individuals aged 50 to 60 years (Ramdass, Petraro et al.
2014).
Increased wage rates increase the returns obtained from days of good health. For
example, if the wage rate increased to $20 from $15, 10 hours of work would bring in
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$200 rather than $150. Therefore, higher wages imply a higher MEI curve, or MEI'. The
higher wage will imply a higher optimal level of health stock in the pure investment
model. The rewards of being healthy are greater for higher-wage workers, so increased
wages will tend to increase workers’ optimal health capital stock. It is now optimal to
increase health stock from H0 to H2. If consumers’ income increases, then any given
price, the consumers are willing and able to purchase more goods or services. Therefore,
the demand for colonoscopies will increase with increases in individuals’ income.
Benarroch-Gampel and colleagues (2012) showed that there was a strong association
between colonoscopy use and income, with higher income groups associated with higher
colonoscopy use (Benarroch-Gampel, Sheffield et al. 2012).

Figure 2.1. Optimal Health Stock
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The effect of education is also illustrated in Figure 1. Here, the MEI curve shows
the marginal efficiency of investment for the consumer with a low level of education,
while the MEI' curve shows the same person with a higher level of education. Education
raises the marginal product of the direct inputs; it reduces the quantity of these inputs
required to produce a given amount of gross investment. Education is seen as improving
the efficiency of producing health, which shifts the MEI curve to the right. More highly
educated people will choose higher optimal health stocks, H2, than will less educated
people, who will choose H0. On the other hand, highly educated individuals are also likely
to recognize the benefits of improved health. They may also enjoy performing physical
exercise or eating healthy food. They may recognize the effects of unhealthy lifestyles,
including smoking cigarettes and drinking alcohol. They may enjoy feeling and looking
good. As such, all else equal, educated individuals will have a greater taste for health
relative to other goods. Therefore, the demand for colonoscopies is expected to increase
with higher education. Previous studies have shown that individuals with higher levels of
educational attainment are more likely to have had screening colonoscopy (Centers for
Disease Control and Prevention 2013, Ramdass, Petraro et al. 2014).
Demand for colonoscopies is affected by gender. Previous studies have shown
that being male is associated with higher levels of screening colonoscopy (Partin,
Gravely et al. 2017). Partine and colleagues (2016) found that women are less likely to
have had a colonoscopy screening than men (Partin, Gravely et al. 2016). Ramdass and
colleagues (2014) found that men were 2.71 times more likely than women to have had a
screening colonoscopy within the past 10 years (Ramdass, Petraro et al. 2014).
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Demand for colonoscopies is affected by location of services. Previous study has
shown that people who live in urban areas are 1.13 times more likely to miss colonoscopy
than people who live in rural or highly rural areas (Partin, Gravely et al. 2016). Eberth
and colleagues (2017) confirmed that there has been substantial growth over time in the
number of facilities and physicians performing colonoscopies in South Carolina, although
certain improvements have been limited to urban counties. For example, the number of
gastroenterologists with a primary office location in rural South Carolina has declined by
13%, whereas urban counties experienced a 17% increase (Eberth, Josey et al. 2017).
Demand for colonoscopies is affected by factors determined by provider and
supply of services. Previous studies have demonstrated that physician supply has been
associated with increased use of colonoscopies (Brouse, Wolf et al. 2008, Haas,
Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al.
2017). Benarroch-Gampel and colleagues (2012) examined the influence of colonoscopist
and primary care physician supply on racial disparities in receipt of colonoscopy and
found that while increasing colonoscopist and primary care physician capacity was
associated with increased colonoscopy use in whites, but it was associated with decrease
in colonoscopy use in blacks and Hispanics (Benarroch-Gampel, Sheffield et al. 2012).
One of the most powerful factors in increasing adherence to CRC screening is provider
recommendation (Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016). A
systematic review has shown that provider recommendation significantly improves
screening rates (Peterson, Ostroff et al. 2016).Researchers have also found that offering
patients a choice of CRC screening through shared decision making, rather than
recommending a single test, can improve adherence to screening (Inadomi, Vijan et al.
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2012, Wolf, Fontham et al. 2018). Furthermore, provider recommendation has been
associated with an increase in use of screening colonoscopy (Ramdass, Petraro et al.
2014). In fact, Ramdass and colleagues (2014) found that provider recommendation for
colonoscopies is the most effective strategy to promote colonoscopy screening in the US
(Ramdass, Petraro et al. 2014).
Demand for colonoscopies is affected by time and travel costs (Petryszyn,
Kempinski et al. 2014). Higher time-cost effectively increases the price of the product. A
colonoscopy requires a clinic visit. Henry and colleagues (2007) conducted a cost
analysis of colonoscopies using micro-costing and time-and-motion techniques to
determine the total societal cost of colonoscopies, including direct health care costs as
well as direct non-health care costs, and costs related to patients’ time (Henry, Ness et al.
2007). The median direct non-health care costs (travel costs and costs of caregivers’ time)
was $226, and indirect costs (related to patient time) was $274 (Henry, Ness et al. 2007).
These time and travel costs may affect demand for colonoscopies. Frew and colleagues
(1999) examined 3,525 respondents from 12 clinical centers in Great Britain that had
carried out flexible sigmoidoscopy for CRC screening. 81% respondents traveled to the
clinic by car, 9% by bus, 4% by taxi, and 2% by train; while 1% walked, and the
remaining 4% came by other means or a combination of modes. Mean travel times for car
and taxi users were significantly shorter than travel times for bus users and other modes
combined. The mean travel cost amounted to $6.10 per person. Mean total time and
travel cost was estimated for a subject as $16.90 and for a screening attendance as
$22.40. By attending clinic-based screening, self-employed individuals lose their
earnings, and that could effectively discourage them from receiving colonoscopies (Frew,
45

Wolstenholme et al. 1999). Moreover, Dong and colleagues (2011) assessed the patterns
and reasons for missed work related to colonoscopy screenings and found that 34% of
working individuals missed work more than one day when their screening was conducted
on a Tuesday, Wednesday, or Thursday. They also found that 32% of workers took sick
leave or vacation leave on the day prior to the colonoscopy, mainly in anticipation of the
bowel preparation; 10% took sick or vacation leave the day after the colonoscopy,
primarily as a precautionary measure following sedation rather than in response to true
symptoms; and 9% took leave days both before and after the day of the colonoscopy.
Moreover, colonoscopy procedures require a significant amount of time investment from
friends and family members. 45% of individuals had friends or family members who also
took leave time for the procedure (Dong, Kalmaz et al. 2011). Dong and colleagues
suggested that these costs may be diminished through patient education about bowel
preparation and what to expect before and after the procedure, and by scheduling more
screening colonoscopies on Monday and Fridays (Dong, Kalmaz et al. 2011).
Demand for colonoscopies is affected by tastes and preferences. Previous studies
have demonstrated that female patients have a preference for female gastroenterologists
for office visits and colonoscopies (Menees, Inadomi et al. 2005, Shah, Karasek et al.
2011, Chong 2012). The main reason for this sex preference is embarrassment, and a
higher level of education is a significant factor in patient embarrassment. Shah and
colleagues (2011) confirmed that more than 30% of female patients would avoid
receiving a colonoscopy if they were unable to have a physician of their sex preference
(Shah, Karasek et al. 2011). Menees and colleagues (2011) also confirmed that 43% of
female patients expressed preference for female colonoscopists; and of these, 87% would
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be willing to wait more than 30 days to access a female colonoscopist (Menees, Inadomi
et al. 2005). Therefore, patient sex preference may affect demand for colonoscopies.
According to a systematic review and meta-analysis study conducted by Lin and
colleagues (2012), patients preferred CT colonography over colonoscopy, and limited
bowel preparations for CT colonography may be the reason for CT colonography
preference (Lin, Kozarek et al. 2012).
Demand for colonoscopies is affected by quality of care. The benefit and risks of
different screening options vary (Knudsen, Zauber et al. 2016, US Preventive Services
Task Force 2016). The USPSTF detailed the estimated number of life years gained, CRC
deaths averted, lifetime colonoscopies required, and resulting complications per 1,000
screened adults aged 50 to 75 for each of the screening strategies (Knudsen, Zauber et al.
2016, US Preventive Services Task Force 2016). Across the different screening methods,
colonoscopies showed highest number of life years gained and CRC deaths averted per
1,000 screened adults aged 50 to 75. On the other hand, colonoscopies also had highest
lifetime colonoscopies required and complications (gastrointestinal and cardiovascular
events) of CRC screening and follow-up testing per 1,000 screened adults aged 50 to 75
years across the different screening methods (US Preventive Services Task Force 2016).
Colonoscopies vary by quality, and high-quality colonoscopies take considerably more
time than the average time physicians spend on colonoscopies (Vicari 2010, Keswani,
Yadlapati et al. 2015, Bitar, Zia et al. 2018). The screening tests have differing levels of
evidence supporting their effectiveness, as well as distinct strengths and limitations, and
demand for colonoscopies will be affected by quality of care provided.
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Demand for colonoscopies is affected by awareness level. Ricardo-Rodrigues and
colleagues (2014) examined awareness levels of colonoscopies as a screening option for
CRC, its uptake, and possible associated factors in confirmed individuals from lower
socioeconomic groups or those who only had primary education or who showed a lower
level of awareness (Ricardo-Rodrigues, Hernandez-Barrera et al. 2014). Hermann and
colleagues (2015) argued that organized CRC screening groups should build a written
invitation system to reduce the sociodemographic-related differential awareness and
colonoscopy uptake (Hermann, Friedrich et al. 2015). Pelto and colleagues (2015)
confirmed that health education and patient navigation programs that increase awareness
of the benefits of colonoscopies may encourage colonoscopy completion. In the context
of language-appropriate patient navigation programs for African-American and Latino/a
individuals, those with lower incomes and English as a second language speakers may
require additional education and counseling to support their decision-making about
having colonoscopies (Pelto, Sly et al. 2015). Therefore, the demand for colonoscopies is
expected to increase with higher awareness levels of colonoscopies.
Demand for colonoscopies is affected by time preference. Future costs and
benefits must be discounted to put them on an equal basis with present values.
Individuals with a high discount rate will be more likely to prefer projects with
immediate payoffs rather than long-term projects. Both education and health require
current outlays to gain distant payoffs. Individuals with lower discount rates will assign
value to the future and will be more likely to invest in both education and health by
receiving cancer screenings. Therefore, the demand for colonoscopies is expected to
increase with lower discount rates.
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Previous studies have confirmed that demand for colonoscopies is influenced by
many factors, including price, price of substitute procedures, age, gender, income,
educational attainment, and supply of providers (Benarroch-Gampel, Sheffield et al.
2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et al. 2013,
Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos 2015,
Partin, Gravely et al. 2016, Grzywacz, Hussain et al. 2017). In this study, we examined
how the ACA cost-sharing reduction has changed colonoscopy use among the elderly
insured and assessed the various factors that affect receipt of colonoscopies.

2.5 Significance
Beginning in September 2010, the ACA required all non-grandfathered private
health plans to offer coverage of CRC screenings without cost-sharing to address the
negative consequences of financial barriers on the use of preventative services and to
promote CRC screening. Consistent with the ACA policy requirement, beginning January
1, 2011, Medicare waived Part B deductibles for all colonoscopies and eliminated
coinsurance for screening colonoscopies, though not for therapeutic ones (Howard, Guy
et al. 2014, Hamman and Kapinos 2015). This study investigated the effect of the ACA’s
removing of financial barriers on the receipt of colonoscopies among insured elderly,
who are predominantly covered by Medicare. Moreover, this study examined how
income-related disparities in colonoscopy use have changed over the past decade and
attempted to quantify various contributions to income-related disparity in the use of
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colonoscopies among insured elderly. Our hypothesis was that the elderly insured
population have a greater likelihood of undergoing colonoscopies following the
implementation of the ACA. We also wanted to determine whether the ACA policy
changes have helped the socioeconomically vulnerable elderly more than others.
Researchers and policy makers have studied the effects of cost-sharing reductions
on the utilization of preventive health care in great detail, but surprisingly, only a few
studies have assessed the effect of cost-sharing reductions on colonoscopies among
elderly insured (including Medicare beneficiaries), following the implementation of the
ACA (Hamman and Kapinos 2015, Cooper, Kou et al. 2016).
The few studies that examined this issue have used a very short time-frame
beginning with the implementation of the ACA, so these studies may underestimate the
effects of policy changes over time. Furthermore, these studies show varied results on the
receipt of colonoscopies following the changes in coverage post-ACA (Fedewa,
Goodman et al. 2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016); and they
have not been able to determine whether eliminating financial barriers have helped the
socioeconomically vulnerable Medicare beneficiaries more than other groups. It is true
that some of the socioeconomically vulnerable elderly may be enrolled in Medicaid; in
which case they would have received colonoscopies without any out-of-pocket expenses
even in pre-ACA years. However, this should not affect the results significantly as almost
all elderly are enrolled in Medicare and only a small percentage are enrolled in Medicaid
(Medicaid only or dually eligible) (Grabowski 2012).
Five cycles (2008, 2010, 2012, 2014, and 2016) of the Behavioral Risk Factor
Surveillance System (BRFSS) were utilized to examine the receipt of colonoscopies
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among insured elderly aged 65 to 75 prior to the implementation of ACA and then again
afterwards. Previous studies, using BRFSS from the years 2008, 2010, and 2012, has
assessed the effect of cost-sharing reduction on colonoscopies among Medicare
beneficiaries following the implementation of the ACA (Hamman and Kapinos 2015).
One study used BRFSS to examine trends in breast and CRC screening in the U.S. by
race, healthcare coverage, and socio-economic status before the Great Recession (20032005), during the recession (2007-2009), and at the beginning of the ACA period (20102012) (Wyatt, Pernenkil et al. 2017). Both these studies used a very short time frame
beginning with the implementation of the ACA, so the studies may underestimate the
effects of policy changes.
This study will contribute to advancing knowledge about the effect of reduction in
cost-sharing on the receipt of colonoscopies among the elderly insured. It is critically
important to know whether reduction of financial barriers alone can improve adherence to
CRC screenings in order to achieve the national goal of 80% by 2018 target and the
HP2020 goal of 71%. Reduction in financial expenses alone may not be enough to reach
the goal, in which case these analyses will be able to indicate other policy options for
improving coverage of colonoscopies. The study will provide scientific evidence on
effect of cost-sharing reduction on the receipt of colonoscopies among the elderly insured
as well as other policy options for improving adherence to CRC screening.
Under current law, Medicare waives coinsurance and deductibles for
colonoscopies. However, when a polyp is discovered and removed, the procedure is
reclassiﬁed as therapeutic for Medicare billing purposes; and beneficiaries become
responsible for paying 20% coinsurance. Therefore, Medicare beneficiaries may face
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unexpected out-of-pocket liabilities when a polyp is detected and removed during a
colonoscopy. The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R.
1017/S. 479) is designed corrected this oversight in current law, but it has yet to become
a formal law. The study will provide supportive evidence to show the benefits of costsharing reductions receipt of colonoscopies among Medicare beneficiaries.
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CHAPTER 3
METHODOLOGY

This study aimed to examine the changes in colonoscopy use among the elderly
insured population, including Medicare beneficiaries, following the implementation of
the ACA policy for preventive services. Our hypothesis was that the elderly insured
population have a greater likelihood of undergoing colonoscopies following the
implementation of the ACA. We also wanted to determine whether the ACA policy
changes have helped the socioeconomically vulnerable elderly more than others. The first
manuscript of the dissertation examined the effect of the ACA cost-sharing reduction on
the receipt of colonoscopy among the elderly insured population. This study aimed to
examine how the ACA cost-sharing reduction has changed colonoscopy use among the
elderly insured and to assess the various factors that affect the receipt of colonoscopies.
The second manuscript examined how disparities in colonoscopy use in the United States
have changed over the past decade, in line with the implementation of the ACA and
attempted to quantify the contributions to the disparity in the use of colonoscopies among
elderly insured.
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3.1 Methods for Manuscript 1
3.1.1 Data and participants
This study used 2008-2016 BRFSS data, an annual, nationally representative
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam,
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff,
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public
health survey in the world; in 2016, the number of completed interviews was 486,303.
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors,
chronic diseases and conditions, access to health care, and use of preventive health
services in the United States.
In 2011 BRFSS added cellular telephone households to adjust for the rapidly
rising percentage of individuals and households in the US with cellular telephones but no
landlines. BRFSS also adopted new methods of weighting to adjust survey data for
differences between the demographic characteristics of respondents and target
populations. Therefore, these two considerations were implemented during the fielding of
the 2011 BRFSS. Since 2011, a new methodology called iterative proportional fitting
(“raking”) replaced the poststratification method to weight BRFSS data (Centers for
Disease Control and Prevention 2012). Raking permits incorporation of cellular
telephone survey data and allows the introduction of additional demographic
characteristics in addition to age-race/ethnicity-gender that improves the degree and
extent to which the BRFSS sample properly reflects the socio-demographic make-up of
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individual states. Preliminary assessments show that the inclusion of cellular telephone
respondents and the change to a new method of weighting may increase prevalence
estimates for health risk behaviors and chronic disease in many states. Although raking
might cause state prevalence trends for certain risk factors to shift upward, in general, the
shape of trend lines over time may not be significantly affected (Centers for Disease
Control and Prevention 2012).
In 2008 the BRFSS began including questions about colonoscopies in even years.
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016.
Previous studies, using BRFSS from the years 2008, 2010, and 2012, has assessed the
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries
following the implementation of the ACA (Hamman and Kapinos 2015). One study used
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare
coverage, and socio-economic status before the Great Recession (2003-2005), during the
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt,
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the
implementation of the ACA, so the studies may underestimate the effects of policy
changes. The sample for this study consists of noninstitutionalized, insured elderly aged
65 to 75 who participated in the survey. For our analyses, only those insured who were in
the age group 65 to 75 years were included, bringing the sample size down to 446,981
adults. We excluded individuals with missing values for variables of interest and those
who refused to answer questions relevant in creating the main measures for the study.
Thus, the analysis sample consisted of 349,899 participants (144,628 men and 205,271
women) aged 65 to 75 years. Figure 3.1 shows the sample size after exclusion of missing
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cases. Table 3.1 presents a study of the analysis sample of 349,899 participants, aged 65
to 75 years, as compared to the overall U.S. Medicare population.

Figure 3.1 BRFSS sample, the exclusion criteria, and the final sample included in the
analysis
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Table 3.1 BRFSS sample compared to the overall U.S. Medicare population
Characteristic
Total
Age (years)
65-66
67-68
69-70
71-72
73-75
Sex
Male
Female
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Region of Residence
Northeast
Midwest
South
West
Household income
Less than $15,000
$15,000 to less than $25,000
$25,000 to less than $35,000
$35,000 to less than $50,000
$50,000 or more
Education
Did not graduate high school
Graduated High School
Attended College
Graduated from College
General health status
Excellent/ Very good
good/ fair
Poor

BRFSS sample
%
100
23
21
19
16
22
48
52
79
9
7
5
18
22
38
22
10
19
14
18
39
12
30
28
29
46
47
7

Characteristic
Total
Age (years)
<65
65-74
75-84
85+

Medicare
%
100

Sex
Male
Female
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Region of Residence
Urban
Rural

Household income
Below poverty
100-125% of poverty
125-200% of poverty
200-400% of poverty
Over 400% of poverty
Education
Did not graduate high school
Graduated High School
Some colleague or more
General health status
Excellent/ Very good
good
Fair/Poor

17
46
25
13

46
54
75
9
10
6
77
23

16
8
20
30
25
20
27
52

45
47
8

Source: MedPAC analysis of the Medicare Current Beneficiary Survey, Cost and Use file 2013

Most Medicare beneficiaries are female and White. More precisely, 54% of the
Medicare population is female and 52% of the BRFSS sample population was female.
75% of the Medicare population is non-Hispanic White and 79% of the BRFSS sample
population was non-Hispanic White. 26% of the Medicare population have no high
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school diploma, but the BRFSS sample showed that 12% of elderly insured have no high
school diploma. Most beneficiaries reported fair to excellent health. Only 8% of the
Medicare population reported poor health; similarly, only 7% of the BRFSS sample
population reported poor health. The BRFSS sample from 2010 to 2016 showed that only
13% of elderly insured have an any types of cancer of any type. However, since there is
no cancer information in is available for 2008, we did not include a cancer status variable
as a covariate.

3.1.2 Variables needed for analyses
Dependent variables
The outcome of interest in our study is the self-reported receipt of colonoscopies
in the previous 10 years. In this study, we will focus on the choice of colonoscopy as
opposed to other recommended CRC screening methods. Colonoscopy is the preferred
screening method because a colonoscopy allows doctors to examine the entire length of
the colon and remove all cancers and precancerous polyps in a single procedure (Levin,
Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016, Benard, Barkun
et al. 2018). A respondent is considered to have received a colonoscopy if he or she
answered “colonoscopy” to the question, “was your last test a sigmoidoscopy or
colonoscopy?”. To determine the years within which the colonoscopy was received, the
responses to the following question was used: “How long has it been since you had your
last sigmoidoscopy or colonoscopy?”. We defined our first outcome variable as a
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dichotomous measure of whether an individual was up-to-date with the USPSTF
screening recommendation. During our study period, the guideline recommended a
colonoscopy be performed once within the previous 10 years. Figure 3.2 shows the
conceptual framework for the current study.

Figure 3.2 Conceptual framework for the current study.

Independent variables
Based on previous studies (Benarroch-Gampel et al., 2012; Cooper et al., 2016;
Hamman & Kapinos, 2015(Ramdass, Petraro et al. 2014)), our analysis included
demographic variables (age, sex, race and ethnicity, marital status, and region of
residence) as possible covariates explaining receipt of colonoscopy. Age is classified into
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five categories: 65-66; 67-68; 69-70; 71-72; and 73-75. Sex is classified into two
categories: male and female. We have incorporated a race and ethnicity variable using the
following discrete categories: non-Hispanic white, non-Hispanic Black, Hispanic, and
other. Marital status is classified into two categories: married and other (divorced,
widowed, separated, never married, and unmarried couple). Region of residence is
classified into four broad geographic regions of the country based on FIPS codes:
Northeast, Midwest, South, and West.
We included two socioeconomic variables in the model as well (household
income and educational attainment). Household income has been reported using the
following income classes: lower than $15,000; $15,000 to $25,000; $25,000 to $35,000;
$35,000 to $50,000; and higher than $50,000. Educational attainment is grouped into four
categories: did not graduate high school; graduated high school; attended college; and
graduated from college.
We pooled all five cycles of the survey into one large data set. The data set
includes individual surveys conducted in two years prior to the ACA policy change (2008
and 2010) and three years after (2012, 2014, and 2016). Medicare, the predominant
insurance provider among elderly, waived deductibles for colonoscopies and eliminated
coinsurance requirements effective January 1, 2011. To capture the effect of policy
change on the receipt of colonoscopies, a policy-shift dummy variable was introduced
into the model.
We used geographic availability of gastroenterologists and degree of health
awareness of surveyed individuals as possible covariates affecting the receipt of
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colonoscopies. The American Medical Association (AMA) Health Workforce Mapper
reports the availability of different specialists by state, and we have used the reported
number of professionally active gastroenterologists (GI) by state to calculate the
geographic availability of GIs per 1000 individuals in a given population. We reported
the geographic availability of gastroenterologists as a quartile of gastroenterologist
availability, meaning we divided the distribution of the variable into four groups having
equal frequencies. The hypothesis was that receipt of colonoscopies will be affected by
the availability of colonoscopy providers in the area. Previous studies have demonstrated
that physician supply has been associated with increased use of colonoscopy (Haas,
Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al.
2017). A recent study reported that the estimated colonoscopy capacity was sufficient to
screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016).
BRFSS does not have any direct measure of individuals’ awareness of
colonoscopy as a screening option or the importance assigned by individuals to
preventive services which have little or no current benefits but improve future health.
One of the concerns in estimating the effect of a policy change over many years is that
during that time, individuals may become more aware of the importance of
colonoscopies, as well as other preventive services. Over the years, the awareness level
may improve due to on-going campaigns to popularize the use of colonoscopies as an
effective approach in preventing CRC. If we assume that knowledge about all preventive
services are interrelated, “effective” use of one or more preventive actions will imply
improvements in knowledge about the importance of colonoscopies. We have decided to
use two proxy measures for this purpose: participation in physical exercise and smoking
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status. Adoption of physical exercise reflects an individual’s willingness to accept a
preventive activity to improve health in the future. Since participation in physical
exercise represents individual’s willingness to spend resources (time and energy) now for
the betterment of health in the future, it may be considered an indirect measure of the
degree of importance the individual assigns to other preventive services like
colonoscopies. Smoking status is a more complex proxy measure, probably reflecting an
individual’s long-term perspective on future health status and the implicit time discount
rate. Smokers are likely to discount future years at a much higher rate than non-smokers
and former smokers. Those with lower time preference rates (lower discount rates) are
more likely to adopt preventive interventions and screenings (Axon, Bradford et al. 2009,
Bradford 2010). We differentiated the individuals in the sample as those who reported
physical exercise within the past 30 days and those who did not. Smoking status was
categorized into three groups: current smoker, former smoker, and never smoked.

3.1.3 Statistical analyses
Descriptive statistics were used to summarize participant characteristics and to
report the number and percentage of participants for each of the variables. In addition, we
reported the percentage of respondents who had a colonoscopy in the previous 10 years
by pre- and post-ACA policy change. We reported the percentage change instead of
actual change as the percentage change method more precisely depicts the changes in
data over a period of time. Bivariate and multivariate logistic models were used to
estimate the effects of reduction in cost-sharing the receipt of colonoscopies among
elderly insured aged 65 to 75. The multivariate models adjusted the outcome variable for
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demographic characteristics (age, sex, race/ethnicity, marital status, and region of
residence), socioeconomic status (household income and educational attainment),
geographic availability of gastroenterologists, health awareness proxies (exercise and
smoking status), and the policy change shifter variable.
The empirical model is as follows:
The receipt of colonoscopy (Yij) = 𝛽0𝑗 + 𝛽1𝑗 (patient age) + 𝛽2𝑗 (patient gender)
+ 𝛽3𝑗 (patient race and ethnicity) + 𝛽4𝑗 (patient marital status) + 𝛽5𝑗 (region of resident) +
𝛽6𝑗 (household income) + 𝛽7𝑗 (educational attainment) + 𝛽8𝑗 (gastroenterologist
availability) + 𝛽9𝑗 (Exercise) + 𝛽10𝑗 (smoking status) + 𝛽11𝑗 (policy change) + 𝛾𝑖𝑗

This model is estimated to reveal the association between Medicare’s cost-sharing
reduction provision and the receipt of colonoscopies among elderly insured aged 65 to
75. We hypothesize that, controlling for observable patient and area resource differences,
elderly insured have a greater likelihood of undergoing colonoscopies following the
implementation of ACA. The primary outcome is the receipt of a colonoscopy within the
previous 10 years, defined as a dichotomous measure of whether an individual was up-todate with the USPSTF screening recommendation. During our study period, the guideline
recommended that one colonoscopy be completed within the past 10 years. We expected
that elderly insured have a greater likelihood of undergoing colonoscopies following the
implementation of the ACA. All statistical analyses were performed using SAS version
9.4 (SAS Inc., Cary, NC, USA).
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3.2 Methods for Manuscript 2
3.2.1 Data and participants
This study used 2008-2016 BRFSS data, an annual, nationally representative
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam,
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff,
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public
health survey in the world; in 2016, the number of completed interviews was 486,303.
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors,
chronic diseases and conditions, access to health care, and use of preventive health
services in the United States.
In 2008 the BRFSS began including questions about colonoscopies in even years.
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016.
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries
following the implementation of the ACA (Hamman and Kapinos 2015). One study using
BRFSS examined trends in breast and CRC screening in the U.S. by race, healthcare
coverage, and socio-economic status before the Great Recession (2003-2005), during the
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt,
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the
implementation of the ACA, so the studies may underestimate the effects of policy
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changes. The sample for this study consists of noninstitutionalized, insured elderly aged
65 to 75 who participated in the survey from the years 2008, 2010, 2012, 2014, and 2016.
For our analyses, only those insured who were in the age group 65 to 75 years were
included, bringing the sample size down to 446,981 adults. We excluded individuals with
missing values for variables of interest and those who refused to answer questions
relevant in creating the main measures for the study. Thus, the analysis sample consisted
of 349,899 participants (144,628 men and 205,271 women) aged 65 to 75 years.

3.2.2 Definition of the Measures Used
The variable of interest for the study is the self-reported receipt of a colonoscopy
in the previous 10 years. A respondent is considered to have received a colonoscopy if
the individual answered “colonoscopy” to the question, “was your last test a
sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy
was received, the responses to the follow-up question were used: “how long has it been
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome
variable as a dichotomous measure of whether an individual was up-to-date with the
USPSTF screening recommendation. During our study period, the guidelines
recommended having a colonoscopy once every 10 years.
The literature has identified several sets of variables to explain variations in
colonoscopy use. We included age, sex, race and ethnicity. Age was categorized into five
groups: 65-66, 67-68, 69-70, 71-72, and 73-75. Sex was classified into two categories:
male and female. Participants’ race and ethnicity was categorized into four groups: non65

Hispanic white, non-Hispanic Black, Hispanic, and other. We dichotomized marital status
as married or not married. We described geographic characteristics by census region
(Northeast, Midwest, South, and West). Based on previous studies (Benarroch-Gampel,
Sheffield et al. 2012, Hamman and Kapinos 2015, Solmi, Von Wagner et al. 2015,
Cooper, Kou et al. 2016), our analysis included household income and educational
attainment. We used a categorical measure of annual household income with the
following categories: lower than $10,000; $10,000 to $14,999; $15,000 to $19,999;
$20,000 to $24,999; $25,000 to $34,999; $35,000 to $49,999; $50,000 to $74,999; and
$75,000 or more. Educational attainment was classified into four categories: did not
graduate high school; graduated high school; attended college; and graduated from
college. Racial and ethnic disparities in CRC screening had already been broadly
documented, and most studies found that individuals belonging to ethnic minorities were
less likely to adhere to screening guidelines; lower socio-economic status (indicating
dimensions such as income, education, and employment status) among ethnic minority
groups is considered the most likely explanation for this finding (Shih, Zhao et al. 2006,
Benarroch-Gampel, Sheffield et al. 2012, Burnett-Hartman, Mehta et al. 2016, Hong,
Tauscher et al. 2017). In addition, lower educational attainment is associated with lower
adherence to CRC screening guidelines (Gimeno Garcia 2012, Kobayashi, Wardle et al.
2014).
The final data set generated for this analysis includes two years of information
prior to the implementation of ACA (2008 and 2010) and three years of information
following the implementation of ACA (2012, 2014, and 2016). Since a large majority of
this group is covered by Medicare, the policy changes adopted by Medicare should have
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significant impact on the use of CRC. For controlling the time trade-off rates of
individuals and willingness to spend resources for improving future health status, we
incorporated two variables in the analysis: whether the individual exercised or not within
previous 30 days and whether the individual is a current smoker, former smoker, or never
smoked.

3.2.3 Concentration index
The concentration index has demonstrated its usefulness as a tool in measuring
health sector disparities. The concentration index measures the degree of disparity in the
utilization of various medical care services or outcomes. To estimate the concentration
index, one variable must be used as the main metric to rank households on the basis of
levels of living or socioeconomic status. We can use household income as the measure to
calculate the concentration index in the use of colonoscopies. The standard concentration
index (CI), denoted below by CI, can be written as follows:
𝑛

2
𝐶𝐼 =
∑ 𝑦𝑖 𝑅𝑖 − 1
𝑛μ
𝑖=1

where 𝑛 is the sample size, 𝑦𝑖 is healthcare utilization of individual 𝑖, μ is its mean and
𝑅𝑖 =

𝑖
𝑁

is the fractional rank of individual 𝑖 in household income distribution. For a

given μ > 0, the maximum of the concentration index is when the poorest 𝑖 individuals
have a value of 𝑦𝑖 equal to zero and the richest 𝑛 − 𝑖 individuals have a value of 𝑦𝑖
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equal to 1. In this case, the value of CI will be maximum at +11. If the poorest person
uses CRC screening and not anyone else, the CI will have the value of -1. If the richest
person uses CRC screening and not anyone else, the CI will have the value of +1. If CI
equals zero, then there is no income-related disparity in the distribution of CRC
screening. As this analysis have used a binary response indicating whether or not a
insured elderly had a recommended colonoscopy, normalized concentration index
employing the Wagstaff decomposition method was applied (Wagstaff 2005). Standard
errors for the normalized index correct for both autocorrelation and heteroscedasticity
(Cai, Coyte et al. 2017).

𝐶𝐼𝑛 =

𝐶𝐼
1−μ

3.2.4 Statistical analyses
We first compared the difference in concentration index between the pre- and
post-ACA periods. Decomposition analysis of the concentration index was used to
determine the impact of a range of sociodemographic variables on any disparity in
colonoscopy use. It was based on the partitioning of total disparity into the precise
disparities observed by each individual regressor (van Doorslaer, Koolman et al. 2004). A
logistic regression was applied with a linear estimation to allow for the correct
decomposition. The following equation shows the linear estimation of the logistic results

1

𝐶𝐼 =

2
𝑛μ

∑𝑛𝑖=1 𝑦𝑖 𝑅𝑖 − 1 =

2
(𝑛−1)μ

𝑛−1

∑𝑖=1 𝑦𝑖 (= 0) 𝑅𝑖 − 1 +

2
(1)μ
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𝑛

∑𝑖=𝑛−1 𝑦𝑖 (= 1) 𝑅𝑖 = 0 − 1 + 2 = +1

where β𝑛𝑘 are the average partial effects of each variable (𝑥) – yielding the likelihood of
a screening colonoscopy (𝑦).
𝑦𝑖 = ∑ β𝑛𝑘 𝑥𝑖𝑘 +𝜀𝑖
𝑘

The following equation shows the decomposition analysis comprised of average
partial effects of each 𝑥 as well as their means and individuals concentration index. In
this equation, the first expression shows the contribution of equivalized income, the
second expression shows effect of other socio-demographic variables perceived to
influence colonoscopy usage, and the final expression refers to the residual term.
β𝑘 𝑥𝑟
𝑥𝑘
𝐺𝐶𝜀
𝐶𝐼𝑛 = (
) 𝐶𝐼𝑟 ∑(𝛽𝑘 ) 𝐶𝐼𝑘 +
μ
μ
μ
𝑘

We presented CIs prior to the ACA policy change (2008 and 2010) and after ACA
implementation (2012, 2014, and 2016). We identified the largest determinant of
disparity observed in pre-ACA years and post ACA years. Positive values of the overall
CIs suggest that colonoscopy use was concentrated among individuals with higher
household incomes. CIs were broken down by confounder and represented as
contributions to the overall income-related disparity in the use of colonoscopies with
percentage contributions in brackets. The percentage contribution is attained by dividing
the absolute contribution by the overall income-related disparity. We included age, sex,
race and ethnicity, marital status, household income, educational attainment, region of
residence, exercise, and smoking status as possible determinants.
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3.3 Ethical approval
This study was reviewed and deemed exempt by the Institution Review Board at the
University of South Carolina (See Appendix).

3.4 Limitations
This study has several limitations. First, the BRFSS is based on self-reports,
which may be subject to recall bias. True screening rates are more likely less than 50%
for adults aged 50 or older (Paskett and Khuri 2015). Therefore, one challenge is
establishing an accurate level of CRC screenings. However, this study was unable to
perform a cross-check with medical records using current data (Ferrante, OhmanStrickland et al. 2008, Schenck, Klabunde et al. 2008). Second, there is also the
possibility of selection bias in this type of survey, as less healthy patients may not be
included in the sample. Third, the BRFSS does not include information about actual outof-pocket expenditures or other possible determinants of screening such as opportunity,
cost of time or difficulty in scheduling colonoscopies. Fourth, this study could not
distinguish between screening and diagnostic colonoscopies. Nonetheless, given the fact
that around 40% of adults who should receive CRC screenings do not receive them
(Joseph, King et al. 2012, Hamman and Kapinos 2015, Paskett and Khuri 2015), finding
an increase in all types of colonoscopies as a result of the Affordable Care Act does
suggest an improvement in CRC detection. Fifth, gastroenterologists are not only
providers of colonoscopy and there are regional variations (Benarroch-Gampel, Sheffield
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et al. 2012, Joseph, Meester et al. 2016). Sixth, there is also the possibility of historical
threats to validity (e.g. increasing awareness over time and social norms in support of
CRC). Seventh, this study could not assess awareness of CRC. Finally, in 2011 BRFSS
changed its weighting methodology with the inclusion of cellular phone-only
respondents. Cellular phone respondents are likely to be different from others in terms of
age and risk of CRC. Therefore, this additional approach of selecting respondents may
have affected the sample of 2011 compared to samples from the pre-2011 period.
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CHAPTER 4
RESULTS

4.1 Manuscript 1

THE EFFECTS OF THE AFFORDABLE CARE ACT ON THE RECEIPT OF COLONOSCOPIES AMONG
INSURED ELDERLY2

2

Lee M. Khan MM. Brant HM. Salloum RG. Chen BK. The Effects of the Affordable Care Act on the
Receipt of Colonoscopies among Insured Elderly. Preparing in Am J Public Health.
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Abstract
Objectives: The Affordable Care Act (ACA) waived deductibles and eliminated
coinsurance for colonoscopies for Medicare beneficiaries beginning in January 1, 2011.
This study investigated the effect of the ACA’s directive to remove the financial barriers
on the receipt of colonoscopies among the elderly insured, who are predominantly
covered by Medicare.
Methods: We used data from the 2008-2016 Behavioral Risk Factor Surveillance System
(BRFSS), an annual, nationally representative survey, to examine the receipt of
colonoscopies for two years prior to the implementation of the ACA (2008 and 2010) and
three years after the change (2012, 2014, and 2016). Multivariate logistic regressions
were estimated to examine the change in colonoscopy use before and after the ACA,
adjusting for patient characteristics and availability of health care providers in the
geographic region.
Results: Of 349,899 eligible elderly insured in the age group 65 to 75 years, 236,275
(67.2%) had received a colonoscopy in the previous 10 years. The receipt of
colonoscopies increased from 63.5% in pre-ACA years to 69.2% in the post-ACA years
(p<.001). Compared with the pre-ACA period, colonoscopy uptake during post ACA
years shows an odds ratio of 1.15 (95% confidence limit [CI] = 1.08-1.22, p<.001) after
adjusting for time dependent improvements in colonoscopies and other relevant factors.
Conclusions: Following the implementation of the ACA, a statistically significant
increase in colonoscopy use was observed. This suggests that eliminating financial
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barriers to access has improved the CRC screening rate, but achieving 80% coverage, the
target rate, will require additional interventions to encourage higher levels of screenings.

Introduction
Colorectal cancer (CRC) is the second leading cause of cancer deaths for both
men and women in the United States (Siegel, Miller et al. 2017). There were an estimated
135,430 new cases of and 50,260 deaths from CRC in 2017 (Siegel, Miller et al. 2017).
Early detection of CRC, through routine screening, has been demonstrated to be effective
in reducing the incidence of and mortality from this disease (Whitlock, Lin et al. 2008,
Edwards, Ward et al. 2010, Siegel, Miller et al. 2017). The U.S. Preventive Services Task
Force (USPSTF) strongly recommends screening for CRC beginning at the age of 50
years and continuing until the age of 75 years for individuals at average risk, implying
that increases in screening for CRC result in decreases of CRC mortality (Whitlock, Lin
et al. 2008, Koretz 2016, US Preventive Services Task Force 2016).
USPSTF recommends a number of screening tests for use in detecting early-stage
CRC and preventing incident cases, including 1) flexible sigmoidoscopy every 5 years, 2)
FIT-DNA every 1 or 3 years, 3) fecal occult blood test or fecal immunochemical testing
every year, 4) CT colonography every 5 years, 5) flexible sigmoidoscopy every 10 years
plus FIT every year, and (6) colonoscopy every 10 years (US Preventive Services Task
Force 2016). The USPSTF recommends screening using any of the accepted methods, as
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any type of screening test would be better than no screening at all (Atkin, Edwards et al.
2010, Quintero, Castells et al. 2012, Patel and Kilgore 2015, US Preventive Services
Task Force 2016). All the screening options are not equally attractive to all individuals;
depending upon health history and preferences of individuals, the choices may differ
significantly. However, from a clinical perspective, colonoscopy is the preferred method,
because a colonoscopy allows doctors to examine the entire length of the colon and
remove all cancers and precancerous polyps during a single procedure (Levin, Lieberman
et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016). Colonoscopy is also
recommended as a follow-up when another CRC screening is positive. Moreover,
colonoscopy has been validated in a randomized trial to have a mortality reduction
benefit (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz 2016, US
Preventive Services Task Force 2016).
The mortality rate from CRC has decreased steadily since 1980 (Weir, Thompson
et al. 2015, Siegel, Miller et al. 2017), which may be partially attributable to removal of
pre-cancerous, adenomatous polyps at an early stage based on a diagnosis of CRC and
widespread use of colonoscopies or other screening approaches (Cunningham, Atkin et
al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin, Tully et al. 2017, Partin,
Gravely et al. 2017). Nonetheless, the self-reported CRC screening rate in the National
Health Interview Survey is at 58%, and the National Committee for Quality Assurance
(NCQA) indicates that 60% of commercial and 69% of Medicare plan members aged
received an appropriate CRC screening in 2016 (Paskett and Khuri 2015). Moreover, the
Behavioral Risk Factor Surveillance System (BRFSS) indicates that around 65% of
adults aged 50 to 75 years have undergone one of the colorectal screening tests
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recommended by USPSTF, and around 60% of adults aged 50 to 75 years received a
colonoscopy within the past 10 years (Joseph, King et al. 2012). These estimates are
lower than the use of preventive interventions for other screening-amenable cancers,
below the 80% coverage of the CRC screening target, and below the HP2020 target of
71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al. 2017).
One potential barrier to CRC screening is the out-of-pocket financial costs
associated with the screenings (Howard, Guy et al. 2014). The financial costs may
significantly dampen patients’ willingness to adopt any preventive procedures, including
any of the CRC screenings. This is especially true for colonoscopies, which usually
involved a relatively high cost-sharing requirement prior to the ACA policy changes in
2011 (Klabunde, Riley et al. 2004, Hamman and Kapinos 2015). Previous studies have
shown that cost-sharing reduces preventive health care use, including the use of highly
effective screening tests (Busch, Barry et al. 2006). One study found that waiving
coinsurance for colonoscopies resulted in an 18% increase in screening (Khatami, Xuan
et al. 2012).
To address the negative consequences of financial barriers on the use of
preventive services and to promote CRC screening, the Affordable Care Act (ACA)
required all non-grandfathered private health plans to offer coverage of CRC screening
without cost-sharing. Consistent with the ACA policy requirement, beginning January 1,
2011, Medicare waived Part B deductibles for all colonoscopies and eliminated
coinsurance for screening colonoscopies, though not for diagnostic ones (Howard, Guy et
al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face
unexpected out-of-pocket liabilities when a polyp is detected and removed during a
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colonoscopy, as these patients are billed a copay. Medicare beneficiaries are also
responsible for Part B deductibles and coinsurance when a colonoscopy is performed as
part of a two-step screening process after another CRC screening is positive (Howard,
Guy et al. 2014). Nevertheless, the ACA policy change, in general, implies that the
elderly insured population should see significant reductions in out-of-pocket expenses
associated with colonoscopies.
Research on the effects of cost-sharing reductions on utilization of preventive
health care has received significant attention from researchers and policy makers, but
surprisingly, only a few studies have assessed the effect of cost-sharing reduction on
colonoscopies among the elderly insured population (including Medicare beneficiaries)
following the implementation of the ACA (Hamman and Kapinos 2015, Cooper, Kou et
al. 2016). The few studies that have examined this issue have used a very short time
frame beginning with the implementation of the ACA, so they may have underestimated
the effects of the ACA cost-sharing reduction. Furthermore, the results of these studies
vary regarding the receipt of colonoscopies following the changes in coverage post-ACA,
(Fedewa, Goodman et al. 2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016)
and they have not been able to determine whether eliminating financial barriers might
have helped socioeconomically vulnerable Medicare beneficiaries more than other
groups. However, some of the socioeconomically vulnerable elderly may be enrolled in
Medicaid, in that case, these individuals would have received colonoscopy without any
out-of-pocket expenses in the pre-ACA years. This should not affect the results
significantly as almost all the elderly are enrolled in Medicare and only a small
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percentage of the elderly are enrolled in Medicaid (Medicaid only or dually eligible)
(Grabowski 2012).
To address these gaps in current research, this study aimed to examine the
changes in colonoscopy use among the elderly insured population, including Medicare
beneficiaries, following the implementation of the ACA policy for preventive services.
Our hypothesis was that the elderly insured population have a greater likelihood of
undergoing colonoscopies following the implementation of the ACA. We also wanted to
determine whether the ACA policy changes have helped the socioeconomically
vulnerable elderly more than others.

METHODS
This study used 2008-2016 BRFSS data, an annual, nationally representative
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam,
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff,
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public
health survey in the world; in 2016, the number of completed interviews was 486,303.
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors,
chronic diseases and conditions, access to health care, and use of preventive health
services in the United States.
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In 2008 the BRFSS began including questions about colonoscopies in even years.
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016.
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries
following the implementation of the ACA (Hamman and Kapinos 2015). One study used
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare
coverage, and socio-economic status before the Great Recession (2003-2005), during the
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt,
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the
implementation of the ACA, so the studies may underestimate the effects of policy
changes. The sample for this study consists of noninstitutionalized, insured elderly aged
65 to 75 who participated in the survey. For our analyses, only those insured who were in
the age group 65 to 75 years were included, bringing the sample size down to 446,981
adults. We excluded individuals with missing values for variables of interest and those
who refused to answer questions relevant in creating the main measures for the study.
Thus, the analysis sample consisted of 349,899 participants (144,628 men and 205,271
women) aged 65 to 75 years. Figure 1 shows the sample size after exclusion of missing
cases.

Main Measures
The outcome of interest in our study is the self-reported receipt of colonoscopies
in the previous 10 years. A respondent is considered to have received a colonoscopy if
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the individual answered “colonoscopy” to the question, “Was your last test a
sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy
was received, the responses to the following question was used: “How long has it been
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome
variable as a dichotomous measure of whether an individual was up-to-date with the
USPSTF screening recommendation. During our study period, the guideline
recommended a colonoscopy be performed once over the previous 10 years.
Based on previous studies (Benarroch-Gampel, Sheffield et al. 2012, Hamman
and Kapinos 2015, Cooper, Kou et al. 2016), our analysis included demographic
variables (age, sex, race and ethnicity, marital status, and region of residence) as possible
covariates explaining adoption of colonoscopy. Age was classified into five categories:
65-66; 67-68; 69-70; 71-72; and 73-75. Sex was classified into two categories: male and
female. We incorporated race and ethnicity variable using the following discrete
categories: non-Hispanic white, non-Hispanic Black, Hispanic, and other. Marital status
was classified into two categories: married and other (divorced, widowed, separated,
never married, and unmarried couple). Region of residence was classified into four broad
geographic regions of the country based on FIPS codes: Northeast, Midwest, South, and
West.
We included two socioeconomic variables in the model as well (household
income and educational attainment). Household income was reported using the following
income classes: lower than $15,000; $15,000 to $25,000; $25,000 to $35,000; $35,000 to
$50,000; and higher than $50,000. Educational attainment was grouped into four
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categories: did not graduate high school; graduated high school; attended college; and
graduated from college.
We pooled all five cycles of the survey into one large data set. The data set
includes individual surveys conducted in the two years prior to the ACA policy change
(2008 and 2010) and the three years after (2012, 2014, and 2016). Medicare, the
predominant insurance provider among the elderly, waived deductibles for colonoscopies
and eliminated coinsurance requirements effective January 1, 2011. To capture the effect
of policy change on the receipt of colonoscopies, a policy-shift dummy variable was
introduced into the model.
We used geographic availability of gastroenterologists and degree of health
awareness of surveyed individuals as possible covariates affecting the receipt of
colonoscopies. The American Medical Association (AMA) Health Workforce Mapper
reports availability of different specialists by state, and we used the reported number of
professionally active gastroenterologists (GI) by state to calculate geographic availability
of GIs per 1000 individuals in a given population. We reported the geographic
availability of gastroenterologists as a quartile of gastroenterologist availability, meaning
we divided the distribution of the variable into four groups having equal frequencies. The
hypothesis was that receipt of colonoscopies will be affected by the availability of
colonoscopy providers in an area. Previous studies have demonstrated that a greater
provider supply has been associated with increased use of colonoscopies (Brouse, Wolf et
al. 2008, Haas, Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth,
Josey et al. 2017).
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BRFSS does not have any direct measure of individual’s awareness of
colonoscopy as a screening option or the importance assigned by individuals to
preventive services which have little or no current benefits but improve future health.
One of the concerns in estimating the effect of a policy change over the years is that
individuals may become more aware of the importance of colonoscopies as well as other
preventive services. Over the years, the awareness level may improve due to ongoing
campaigns to popularize the use of colonoscopy as an effective approach in preventing
CRC. If we assume that knowledge about all the preventive services are interrelated,
“effective” use of one or more of preventive actions will also imply improvements in
knowledge about the importance of colonoscopies. We decided to use two proxy
measures for this purpose: participation in physical exercise and smoking status.
Adoption of physical exercise reflects an individual’s willingness to accept a preventive
activity to improve health in the future. Since participation in physical exercise represents
an individual’s willingness to spend resources (time and energy) now for the betterment
of health in the future, it may be considered an indirect measure of the degree of
importance individuals assign to other preventive services like colonoscopies. Smoking
status is a more complex proxy measure, probably reflecting the individual’s long-term
perspective on future health status and the implicit time discount rate. Smokers are likely
to discount future years at a much higher rate than non-smokers and former smokers.
Those with lower time preference rate (lower discount rate) are more likely to adopt
preventive interventions and screenings (Axon, Bradford et al. 2009, Bradford 2010). We
differentiated the individuals in the sample as those who reported physical exercise
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within the last 30 days and those who did not. Smoking status was categorized into three
groups: current smoker, former smoker, and never smoked.

Statistical Analyses
Descriptive statistics were used to summarize participant characteristics and to
report the number and percentage of participants for each of the variables. We also
reported the percentage of respondents who had a colonoscopy in the previous 10 years
by pre- and post-ACA policy change. We reported the percentage change instead of
actual change as the percentage change method more precisely depicts the changes in
data over a period of time. Bivariate and multivariate logistic models were used to
estimate the effects of the policy-shift on the receipt of colonoscopies among insured
elderly aged 65 to 75 years. The multivariate models adjusted the outcome variable for
demographic characteristics (age, sex, race/ethnicity, marital status, and region of
residence), socioeconomic status (household income and educational attainment),
geographic availability of gastroenterologists, health awareness proxies (exercise and
smoking status), and the policy change shifter variable. Sampling weights were used to
derive national estimates for the sample included in this analysis. All statistical analyses
were performed using SAS version 9.4 (SAS Inc., Cary, NC, USA).

RESULTS
The data set had 349,899 adults aged 65 to 75 years (Table 4.1). Non-Hispanic
whites were the largest racial and ethnic group (78.7%), followed by Non-Hispanic
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blacks (9.2%), Hispanics (7.1%), and other (5.1%). The majority of participants were
female (58.7%), married (54.8%), had exercised in the last 30 days (72.7%), and had
received a colonoscopy within the last 10 years (67.5%). Figure 4.2 presented the
percentage of participants who received a colonoscopy in the last 10 years from 2008 to
2016. During the period from 2008 to 2016, 236,275 participants received a
recommended colonoscopy (67.2%). Colonoscopy use increased from 61.2% in 2008 to
69.9% in 2016 (p<.0001).
Table 4.2 showed colonoscopy use before and after the implementation of the
ACA. Compared with Non-Hispanic blacks, Hispanics, and other participants, NonHispanic white participants were more likely to have received a colonoscopy in the last
10 years (p<.0001). Compared with individuals living in the South, Midwest, and West
regions, individuals living in the Northeast were more likely to receive a recommended
colonoscopy (p<.0001). Compared with participants who had a household income under
$15,000, participants with a household income greater than $50,000 were more likely to
receive the recommended colonoscopy (p<.0001). We found that the receipt of
colonoscopies increased after implementation of the ACA, and that increases were largest
among the socioeconomically vulnerable elderly (Table 4.2). Overall, the receipt of
colonoscopies increased from 63.5% in pre-ACA years to 69.2% in post-ACA years
(p<.0001) (Figure 4.3). The receipt of colonoscopies increased by 15.1% among the
elderly insured with household incomes under $15,000, but only by 6.5% among those
with household incomes greater than $50,000. The receipt of colonoscopies increased by
15.9% among elderly insured who did not graduate high school, but by 7.3% among
elderly insured who graduated from college. Rates of colonoscopy use by household
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income and individual educational attainment indicated larger gains among the
socioeconomically vulnerable elderly (Table 4.2).
Figure 4.4 (a) and (b) showed colonoscopy use before and after the
implementation of the ACA by household income and educational attainment. We found
that the receipt of colonoscopies increased after the implementation of the ACA for all
household income groups, and the increase was the largest among individuals with less
than $15,000 household income. In terms of educational attainment, receipt of
colonoscopies increased for all groups, but the increases were largest among individuals
who did not graduate high school.
Table 4.3 reports the results of the multivariate analysis of factors associated with
colonoscopy use over the previous 10 years. Increased use of colonoscopy was associated
with older age, being female, exercise status, and smoking status. After controlling for
demographic characteristics, socioeconomic status and other relevant variables, the
policy shift variable was statistically significant, implying that colonoscopy use increased
among the elderly insured after the implementation of the ACA (OR, 1.15; 95%
confidence limit [CI], 1.08-1.22), given various socioeconomic, demographic and other
relevant covariates. Female participants were 1.19 times more likely to receive a
recommended colonoscopy than male participants (OR=1.19, CI, 1.15-1.22). NonHispanic blacks were significantly more likely (OR=1.16, CI, 1.10-1.23) and Hispanics
were significantly less likely (OR=0.78, CI, 0.72-0.84) to receive recommended
colonoscopies, compared with non-Hispanic whites.
We found a strong positive association between being married and the probability
of receiving a colonoscopy. Married participants were more likely to receive a
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recommended colonoscopy compared to unmarried participants. Individuals living in the
highest quartile of gastroenterologist availability states were significantly more likely
(OR=1.15, CI, 1.10-1.21) to receive recommended colonoscopies compared with
individuals living in the lowest quartile of gastroenterologist availability states.
Individuals who had exercised in the past 30 days were 1.23 times more likely to have
received a recommended colonoscopy compared with individuals who hadn’t exercised
in the past 30 days (OR=1.23, CI, 1.19-1.27). Former smokers (OR=1.71, CI, 1.63-1.80)
and those who never smoked (OR=1.50, CI, 1.43-1.57) were significantly more likely to
have received a recommended colonoscopy compared with current smokers (Table 4.3).
Individuals with a household income greater than $50,000 were 2.10 times more
likely to have received a recommended colonoscopy compared with individuals whose
household income was less than $15,000 (OR=2.10, CI, 1.97-2.24). Individuals who
graduated from college were 1.53 times more likely to have received a recommended
colonoscopy compared with individuals who did not graduate high school (OR=1.53, CI,
1.44-1.63). We tested interaction terms combining policy shift variable with
race/ethnicity, educational attainment, and household income; but none of the interaction
terms were statistically significant. This implies that the effect of race/ethnicity,
education, and income on colonoscopy adoption did not change in the post-ACA
environment when compared to pre-ACA situation.
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DISCUSSION
Analysis of BRFSS data indicates that the receipt of colonoscopies among the
elderly insured increased from 63.5% in pre-ACA years to 69.2% in post-ACA years.
Elderly insured in the age group 65 to 75 years (most of whom are Medicare
beneficiaries) are 1.15 times more likely to be up-to-date with colonoscopy screening
after the policy change when compared to their pre-ACA status, after controlling for a
number of individual and geographic factors. Although the analysis could not incorporate
out-of-pocket expenses directly into the model due to lack of data, it is likely that the
increase in colonoscopy uptake observed in the post-ACA years was due to the reduction
in cost-sharing. Increased coverage of colonoscopy appears to be more pronounced
among elderly insured who are less educated and in lower household income groups.
Consistent with earlier research findings (Hamman and Kapinos 2015), our results
confirmed that there was a statistically significant increase in colonoscopy use among
elderly beneficiaries aged 65 to 75 years after the implementation of the ACA. The
results also correspond with prior literature showing a positive association between costsharing reduction and utilization of recommended preventive services (Goodwin and
Anderson 2012, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016, Misra, Lloyd et
al. 2018). However, even with higher coverage of colonoscopies after ACA
implementation, approximately half of the elderly insured in the age group 65-75 years
with household income less than $15,000 received a recommended colonoscopy.
Moreover, 55.5% of the elderly insured aged 65-75 years without a high school diploma
received a colonoscopy in the previous 10 years in post-ACA years. Therefore, even after
significant reduction in out-of-pocket expenses for receiving colonoscopies, the coverage
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of colonoscopy remains suboptimal and much lower than the 80% target by 2018. It is
important to identify specific approaches to encourage socioeconomically disadvantaged
elderly to seek colonoscopies in order to achieve a higher rate of progress in achieving
the target 80%, even though increases in colonoscopy uptake were the largest among the
lower income and education groups in post-ACA levels compared to pre-ACA levels.
Nonetheless, we found a significant increase in colonoscopy use among elderly
insured with lower socioeconomic status after implementation of the ACA. This may, in
part, reflect the effect of removal of out-of-pocket costs, since financial barriers are found
to reduce coverage of cancer screening (Doubeni, Laiyemo et al. 2010), and
colonoscopies are expensive (Pyenson, Scammell et al. 2014). It is also possible that the
increase in the receipt of colonoscopies among lower socioeconomic groups may reflect
the continuation of increasing trends that have been observed nationwide, as well as the
proliferation of private health plans (Klabunde, Cronin et al. 2011, Shapiro, Klabunde et
al. 2012, Wernli, Hubbard et al. 2014). It is clear that the increase was universal across
socioeconomic status and not limited to subjects with lower income and lower levels of
education. However, despite the improvements in colonoscopy uptake over the years, the
poorest and the most socially disadvantaged groups represent the highest potential for
improvement, given their relatively low rates of colonoscopy use. For achieving the
target screening rate, additional interventions should be considered in addition to the
lowering of barriers to access. The ACA’s reduction of financial barriers has improved
adherence to CRC screening, but other non-medical costs should be considered more
carefully to rapidly improve the screening rates.
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There are several barriers to the receipt of colonoscopies other than cost,
including perceived loss of utility associated with bowel preparation prior to the test,
logistical challenges, not receiving a physician’s recommendation for CRC screening,
and believing that CRC screening is not important or necessary (McAlearney, Reeves et
al. 2005, Guessous, Dash et al. 2010, Jones, Devers et al. 2010). Patients’ perception of
insurance coverage has been shown to deter cancer screening use (McAlearney, Reeves
et al. 2005), which indicates the need for improved awareness of the ACA’s cost-sharing
reduction provision among the elderly insured population. The Medicare program needs
to ensure that all Medicare beneficiaries are aware of the new policy, that part B do not
require any deductible or coinsurance for screening colonoscopies. Eliminating the costsharing for therapeutic colonoscopies could be the next policy reform to be considered in
improving adherence to colorectal cancer screening even further (Hamman and Kapinos
2015).
Previous studies found divergent results of post-ACA changes in CRC screenings
among the elderly and Medicare beneficiaries (Fedewa, Goodman et al. 2015, Hamman
and Kapinos 2015, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). Some
studies found an increase in the receipt of CRC screening (Fedewa, Goodman et al. 2015,
Hamman and Kapinos 2015), while others found no change in the use of any cancer
screening procedure (Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). Unlike
these studies, our study was able to use a longer time-frame to examine the effect of ACA
policy changes on colonoscopy use. With this longer time lapse since implementation of
the ACA, we found a significant effect of policy change when many other potential
factors affecting colonoscopy uptake had been controlled for. We even incorporated the
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availability of health care providers in the area as a control factor, something none of the
earlier analyses had considered. The supply-side variable indicates that the availability of
GIs in the geographic area affects the likelihood of receiving a colonoscopy within the
recommended time frame.
This study has several limitations. First, the BRFSS is based on self-reports,
which may be subject to recall bias. True screening rates are more likely to be less than
50% for adults aged 50 years or older (Paskett and Khuri 2015). Therefore, one challenge
is establishing the accurate rate of colonoscopy receipt. The BRFSS did not carry out
cross-checking of reported colonoscopy with individuals’ medical records (Ferrante,
Ohman-Strickland et al. 2008, Schenck, Klabunde et al. 2008). Second, there is also a
possibility of selection bias in this type of survey because less healthy patients may not
be included in the sample. Third, the BRFSS does not include information about actual
out-of-pocket expenditures or other non-medical expenses associated with the screening,
such as opportunity cost associated with time or difficulty in scheduling colonoscopies
(Dong, Kalmaz et al. 2011, Petryszyn, Kempinski et al. 2014). Fourth, this study could
not distinguish between screening and therapeutic colonoscopies and whether or not the
ACA policy itself changed the providers’ behavior in terms of recommending screening
or therapeutic colonoscopies. Fifth, gastroenterologists are not only providers of
colonoscopy and there are regional variations (Benarroch-Gampel, Sheffield et al. 2012,
Joseph, Meester et al. 2016). Sixth, there is also the possibility of historical threats to
validity (e.g. increasing awareness over time and social norms in support of CRC).
Seventh, this study could not assess awareness of CRC. Finally, in 2011 BRFSS changed
its weighting methodology through the inclusion of cellular phone respondents. Cellular
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phone respondents are likely to be different from others in terms of age and risk of CRC.
Therefore, this additional approach of selecting respondents may have affected the
sample of 2011 in comparison with samples from the pre-2011 period.
In summary, our results confirmed that there was a statistically significant
increase in colonoscopy use among the elderly insured aged 65 to 75 years after the
implementation of the ACA. Although Medicare waived Part B deductibles for all
colonoscopies and eliminated coinsurance for screening colonoscopies, individuals are
still subject to out-of-pocket medical expenses for therapeutic colonoscopies (Hamman
and Kapinos 2015). Our results indicate that the ACA’s reduction of financial barriers has
improved usage of CRC screening and further improvements will be possible if the costs
associated with therapeutic colonoscopies can be reduced or eliminated. Policy makers
should also try to understand other related expenses, both medical and non-medical costs,
associated with the receipt of colonoscopies by the elderly (Dong, Kalmaz et al. 2011,
Petryszyn, Kempinski et al. 2014). Reducing these costs will also help achieve the
national target rate of colonoscopy use. Moreover, our results indicate that greater
provider supply has been associated with increased use of colonoscopies. An increased
supply of providers may have little beneficial effect on race and ethnic disparities in the
receipt of colonoscopies or on geographic disparities in the receipt of colonoscopies
(Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 2017). Interventions should
focus on improving screening in populations living in rural areas and among minorities.
A recent study reported that the estimated colonoscopist capacity was sufficient to screen
80% of the eligible U.S. population (Joseph, Meester et al. 2016). However,
colonoscopies vary in quality, and high-quality colonoscopies take considerably more
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time than that which the average physician spends on such a procedure (Vicari 2010). If a
particular area has a short supply of gastroenterologists, short-run alternatives may be
possible, such as training primary care providers to conduct colonoscopies (Selby,
Cornuz et al. 2016).
The results of this study indicate that the use of colonoscopies increased among
the elderly insured after the implementation of the ACA cost-sharing rule for preventive
services. Reduction of financial barriers has been effective in improving CRC screening,
and further reduction in financial barriers is likely to improve uptake of CRC screening in
the future. The financial barriers are not only due to medical care costs but also due to
other non-medical expenses, and policy makers should consider how to improve access to
preventive services by considering all the potential barriers to access. In general,
lowering out-of-pocket expenses for colonoscopies has improved receipt of
colonoscopies by all elderly groups; but the increase in coverage was higher for poorer
individuals and individuals with low educational attainment. Therefore, reduction in outof-pocket expenses benefited the disadvantaged elderly population at a higher rate than
other elderly groups.
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Table 4.1. Characteristics of Survey Participants Aged 65 to 75 Years: Behavioral Risk Factor Surveillance System (BRFSS), 2008-2016
Total
Pre-ACA (2008, 2010)
Post-ACA (2012, 2014, 2016)
Characteristic
N
Weighted N
%
N
Weighted N
%
N
Weighted N
%
Total
349,899
20,760,005
100.0
125,577
7,292,561
100.0
224,322
13,467,444
100.0
Age (years)
65-66
78,424
4,778,975
23.0
27,686
1,657,607
22.7
50,738
3,121,369
23.2
67-68
72,261
4,293,712
20.7
25,928
1,492,646
20.5
46,333
2,801,066
20.8
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69-70
71-72
73-75

65,746
56,989
76,479

3,853,545
3,307,273
4,526,499

18.6
15.9
21.8

22,953
20,739
28,271

1,308,456
1,187,668
1,646,184

17.9
16.3
22.6

42,793
36,250
48,208

2,545,089
2,119,606
2,880,315

18.9
15.7
21.4

Sex
Male

144,628

10,041,253

48.4

49,856

3,498,723

48.0

94,772

6,542,530

48.6

Female

205,271

10,718,752

51.6

75,721

3,793,838

52.0

129,550

6,924,915

51.4

Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other

300,176
23,541
11,393
14,789

16,335,132
1,900,058
1,464,786
1,060,030

78.7
9.2
7.1
5.1

107,573
8,262
4,523
5,219

5,787,662
625,413
515,157
364,328

79.4
8.6
7.1
5.0

192,603
15,279
6,870
9,570

10,547,470
1,274,645
949,629
695,702

78.3
9.5
7.1
5.2

191,812

13,062,607

62.9

67,832

4,791,316

65.7

123,980

8,271,291

61.4

63,156
83,992
117,730

3,721,267
4,610,164
7,807,516

17.9
22.2
37.6

21,448
27,263
45,098

1,333,058
1,611,787
2,740,775

18.3
22.1
37.6

41,708
56,729
72,632

2,388,209
2,998,377
5,066,741

17.7
22.3
37.6

West

85,021

4,621,059

22.3

31,768

1,606,941

22.0

53,253

3,014,117

22.4

Household income
Less than $15,000
$15,000 to less than $25,000
$25,000 to less than $35,000

37,975
71,719
51,045

2,132,736
3,999,888
2,896,727

10.3
19.3
14.0

16,145
28,776
20,179

799,267
1,493,125
1,105,098

11.0
20.5
15.2

21,830
42,943
30,866

1,333,470
2,506,764
1,791,628

9.9
18.6
13.3

Married
Region of Residence
Northeast
Midwest
South

$35,000 to less than $50,000

61,885

3,648,907

17.6

22,442

1,296,287

17.8

39,443

2,352,620

17.5

$50,000 or more
Education
Did not graduate high school
Graduated High School

127,275

8,081,747

38.9

38,035

2,598,784

35.6

89,240

5,482,963

40.7

28,997
107,851

2,565,191
6,286,535

12.4
30.3

13,251
43,068

834,555
2,350,414

11.4
32.2

15,746
64,783

1,730,636
3,936,121

12.9
29.2

92,346

5,878,894

28.3

31,705

1,770,625

24.3

60,641

4,108,269

30.5

Graduated from College

120,705

6,029,384

29.0

37,553

2,336,966

32.0

83,152

3,692,418

27.4

Colonoscopy within 10 years
No
Yes

113,624
236,275

6,815,019
13,944,986

32.8
67.2

46,619
78,958

2,660,497
4,632,063

36.5
63.5

67,005
157,317

4,154,522
9,312,922

30.8
69.2

1,810,049
5,347,096
7,348,162
6,254,698

8.7
25.8
35.4
30.1

20,757
39,196
33,101
32,523

636,937
1,864,253
2,566,325
2,225,046

8.7
25.6
35.2
30.5

38,566
71,138
53,268
61,350

1,173,112
3,482,844
4,781,836
4,029,653

8.7
25.9
35.5
29.9

5,765,920
14,994,085

27.8
72.2

36,007
89,570

2,027,556
5,265,004

27.8
72.2

59,607
164,715

3,738,364
9,729,081

27.8
72.2

Attended College
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Quartile of Gastroenterologist Availability*
59,323
Q1
110,334
Q2
86,369
Q3
93,873
Q4
Exercise in past 30 days
No
Yes
Smoking Status
Current smoker

95,614
254,285

40,547
2,331,537
11.2
15,127
808,134
11.1
25,420
1,523,403
11.3
149,275
9,133,039
44.0
55,012
3,271,931
44.9
94,263
5,861,108
43.5
Former smoker
160,077
9,295,429
44.8
55,438
3,212,495
44.1
104,639
6,082,934
45.2
Never smoked
Note. *Gastroenterologist availability quartiles are determined by the number of gastroenterologists per 1,000 (2010) in the respondent’s state. The American
Medical Association (AMA) Health Workforce Mapper reports the availability of different specialists by state, and we have used the reported number of
professionally active Gastroenterologists by state to calculate the geographic availability of GIs per 1000 individuals in a given population.

Table 4.2. Colonoscopy Use Before and After Implementation of The Affordable Care Act Policy
Change: Behavioral Risk Factor Surveillance System (BRFSS), 2008-2016
Colonoscopy within the past 10 years
Variables
Pre ACA
Post ACA
Differences
%
%
% Change
Total
63.5
69.2
8.9
Age (years)
65-66
62.2
67.3
8.2
67-68
63.5
69.9
10.0
69-70
64.2
69.8
8.7
71-72
63.8
70.1
9.8
73-75
64.1
69.2
7.9
Sex
Male
63.7
68.7
7.9
Female
63.4
69.6
9.8
Race/ethnicity
Non-Hispanic White
65.5
70.9
8.2
Non-Hispanic Black
61.4
70.0
14.0
Hispanic
50.0
56.2
12.5
Other
54.8
59.2
8.1
Married
Yes
66.7
72.4
8.6
No
57.5
64.0
11.4
Region of Residence
Northeast
67.3
71.9
6.8
Midwest
64.7
70.2
8.4
South
63.9
70.2
9.8
West
58.5
64.2
9.8
Household income
Less than $15,000
45.5
52.4
15.1
$15,000 to less than $25,000
55.7
61.1
9.6
$25,000 to less than $35,000
63.4
67.1
5.9
$35,000 to less than $50,000
66.4
71.0
6.9
$50,000 or more
72.1
76.8
6.5
Education
Did not graduate high school
47.9
55.5
15.9
Graduated High School
61.2
66.8
9.3
Attended College
64.4
71.0
10.3
Graduated from College
70.8
76.0
7.3
Quartile of Gastroenterologist Availability
Q1
59.5
66.5
11.8
Q2
64.2
70.4
9.6
Q3
61.2
66.9
9.3
Q4
66.7
71.5
7.2
Exercise in past 30 days
No
57.0
63.0
10.5
Yes
66.0
71.5
8.3
Smoking Status
Current smoker
49.0
55.7
13.8
Former smoker
66.8
71.8
7.6
Never smoked
63.8
69.9
9.5
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Table 4.3. Multivariate Analysis of Factors Associated with Colonoscopy Use: Behavioral Risk
Factor Surveillance System (BRFSS), 2008-2016
Colonoscopy within the past 10 years
OR
(95% CI)
Policy shift
1.15
1.08
1.22
Age (years)
65-66
1.00
67-68
1.11
1.06
1.16
69-70
1.15
1.09
1.20
71-72
1.16
1.11
1.22
73-75
1.16
1.11
1.21
Sex
Male
1.00
Female
1.19
1.15
1.22
Race/ethnicity
Non-Hispanic White
1.00
Non-Hispanic Black
1.16
1.10
1.23
Hispanic
0.78
0.72
0.84
Other
0.70
0.64
0.77
Married
Yes
1.00
No
0.84
0.82
0.87
Region of Residence
Northeast
1.00
Midwest
0.98
0.92
1.03
South
0.98
0.93
1.03
West
0.74
0.70
0.79
Household income
Less than $15,000
1.00
$15,000 to less than $25,000
1.25
1.18
1.33
$25,000 to less than $35,000
1.53
1.44
1.63
$35,000 to less than $50,000
1.69
1.59
1.80
$50,000 or more
2.10
1.97
2.24
Education
Did not graduate high school
1.00
Graduated High School
1.24
1.17
1.31
Attended College
1.37
1.29
1.45
Graduated from College
1.53
1.44
1.63
Quartile of Gastroenterologist Availability
1.00
Q1
1.15
1.11
1.19
Q2
1.06
1.02
1.10
Q3
1.15
1.10
1.21
Q4
Exercise in past 30 days
1.00
No
1.23
1.19
1.27
Yes
Smoking Status
1.00
Current smoker
1.71
1.63
1.80
Former smoker
1.50
1.43
1.57
Never smoked
1.03
1.02
1.04
Years
Note: CI= confidence interval; OR= odds ratio.
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Figure 4.1. BRFSS sample, the exclusion criteria, and the final sample included in the
analysis.
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Colonoscopy within past 10yrs (%)

100.0
90.0
80.0
70.0

61.2

65.7

68.0

69.4

69.9

2010

2012

2014

2016

60.0
50.0
40.0
30.0
20.0
10.0
2008

Year
Colonoscopy use (%)

Linear (Colonoscopy use (%))

Figure 4.2. Percentage of participants who received a colonoscopy in the previous 10 years
from 2008 to 2016
*Statistically significant difference at P<0.05.
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Colonoscopy use within the past 10 years (%)
100.0
90.0
80.0
70.0

69.2

63.5

60.0
50.0
40.0
30.0
20.0
10.0
Pre ACA (2008-2010)

Post ACA (2012-2016)

Figure 4.3. Changes in receipt of colonoscopy among insured Elderly aged 65 to 75 years.
*Statistically significant difference at P<0.05.
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Colonoscopy Use (%)

100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

45.5

52.4

55.7

63.4

61.1

Less than $15,000 $15,000 to less
than $25,000

67.1

66.4

$25,000 to less
than $35,000

72.1

71.0

76.8

$35,000 to less $50,000 or more
than $50,000

Household Income
PreACA

PostACA

Colonoscopy Use (%)

Figure 4.4 (a). Colonoscopy use before and after implementation of the ACA by household
income. *Statistically significant difference at P<0.05.

100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

55.5

61.2

66.8

64.4

71.0

70.8

76.0

47.9

Did not graduate
high school

Graduated High
School

Attended College

Graduated from
College

Educational Attainment
PreACA

PostACA

Figure 4.4 (b). Colonoscopy use before and after implementation of the ACA by
educational attainment. *Statistically significant difference at P<0.05.
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Odds Ratio

2.10
1.53
1.00

1.15

1.69

1.25

1.24

1.00

1.37

1.53

1.00

Colonoscopy Use within the past 10 years

Figure 4.5. Multivariate logistic model for factors associated with colonoscopy use.
*Statistically significant.
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Abstract
Background: Increases in CRC screening rates have been demonstrably effective in
reducing the incidence of and mortality from this disease, but the use of CRC screening
remains lower than the use of preventive interventions for other screening-amenable
cancers; and CRC screening rates are below the 80% NCCRT target coverage and the
70% HP2020 target coverage.
Objective: The objectives of this paper are to examine how income-related disparities in
CRC screening in the United States have changed over the past decade, especially in the
years prior to and after the implementation of Affordable Care Act (ACA) and to quantify
the contributions of different factors in explaining the disparity in the use of
colonoscopies among elderly population with health insurance coverage.
Methods: Five cycles (2008, 2010, 2012, 2014, and 2016) of Behavioral Risk Factor
Surveillance System (BRFSS) data were utilized. To examine income-related disparities
in the use of CRC, individuals aged 65 to 75 were included, and the Concentration Index
(CI) was calculated before and after the implementation of ACA. To identify and
quantify the contribution of different factor, a decomposition analysis of CI was
conducted.
Results: CIs decreased from 0.1935 in pre-ACA years to 0.1813 in the post-ACA years
among the elderly, indicating that the disparity in the use of colonoscopy was relatively
low and the disparity index declined after the implementation of ACA. Decomposition
analyses showed that whereas decreases in disparities derived largely from income and
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educational level, higher level of income and educational attainment were major
contributors to the observed disparities in colonoscopy use.
Conclusions: Our findings indicate that the ACA’s removal of financial barriers may
have contributed towards the reduction in disparity of colonoscopy use. It appears that
financial aspects will not be adequate for further reduction in disparity. More direct
interventions, e.g., improved knowledge, better access and lower indirect cost will be
helpful in improving screening among low income and low educational attainment
households.

Keywords: Colonoscopy, Disparity, Concentration Index, Decomposition

Introduction
The incidence of and mortality rates from colorectal cancer (CRC) have been
steadily decreasing in the United States (US) since the 1980s (Weir, Thompson et al.
2015, Siegel, Miller et al. 2017). This may, in part, be due to substantial advances in
screening, a general agreement among health care providers and policy-makers in
screening recommendations and evidence of cost-effectiveness of screening
(Cunningham, Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, US
Preventive Services Task Force 2016, Martin, Tully et al. 2017, Partin, Gravely et al.
2017). Increases in screening have been demonstrably effective in reducing the incidence
of and mortality from this disease, and they explain about half of the observed decrease in
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these rates (Whitlock, Lin et al. 2008, Edwards, Ward et al. 2010, Siegel, Miller et al.
2017).
The U.S. Preventive Services Task Force (USPSTF) strongly recommends that for
individuals at average risk, CRC screening should begin at age 50 and continue until age
75. The recommendation is guided by the evidence that screening for CRC generates
substantial net benefits for the target group (Whitlock, Lin et al. 2008, Koretz 2016, US
Preventive Services Task Force 2016). The USPSTF recommends screening by any of
the accepted methods, as any sort of screening test is better than no screening at all
(Atkin, Edwards et al. 2010, Quintero, Castells et al. 2012, Patel and Kilgore 2015). Not
all screening options, however, are equally attractive to all individuals; depending upon
individuals’ health history and preferences, the choices may vary significantly. From a
clinical perspective, colonoscopy is the most preferred method, because an effective
colonoscopy allows doctors to examine the entire length of the colon and to remove all
cancers and precancerous polyps, if found, in the same procedure (Levin, Lieberman et
al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016). Colonoscopy is also
recommended as a follow-up when another CRC screening is positive. Moreover,
colonoscopy has been validated in a randomized trial as providing a clear mortality
reduction benefit (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz 2016, US
Preventive Services Task Force 2016).
Nonetheless, the self-reported CRC screening rate in the 2013 National Health
Interview Survey was only 58%, and the National Committee for Quality Assurance
(NCQA) indicates that 60% of commercial insurance buyers and 68.5% of Medicare plan
members received an appropriate CRC screening in 2016 (Paskett and Khuri 2015). The
109

Behavioral Risk Factor Surveillance System (BRFSS) data indicate that around 65% of
adults aged 50 to 75 have undergone one of the colorectal screening tests recommended
by USPSTF, and around 60% of adults aged 50 to 75 have received a colonoscopy within
the past 10 years (Joseph, King et al. 2012).
Previous studies have identified the determinants of CRC screening disparities,
and the majority of studies have found that individual socioeconomic status (SES) is an
important determinant (Courtney, Paul et al. 2013, Fedewa, Ma et al. 2015, Meyer, Allard
et al. 2016, White, Thompson et al. 2017). Growing evidence indicates that screening
colonoscopy is most likely among individuals with higher income, even among insured
population (Benarroch-Gampel, Sheffield et al. 2012, Centers for Disease Control and
Prevention 2013, Solbak, Xu et al. 2018). Healthy People 2020 (HP2020) has four
overarching goals: to attain high-quality, longer lives free of preventable disease, to
create social and physical environments, to promote quality of life, healthy development,
and healthy behaviors, and to eliminate disparities (White, Thompson et al. 2017).
Understanding the temporal trends in disparities as well as the factors explaining the
disparities are important in formulating policy options to reduce disparity in the use of
screening tests like colonoscopy (White, Thompson et al. 2017). To increase CRC
screening rates and reduce the disparities in screening, beginning January 1, 2011,
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for
screening colonoscopies (Howard, Guy et al. 2014, Hamman and Kapinos 2015).
Individuals with other type of insurance coverage also saw their out-of-pocket costs
decline after the implementation of ACA.
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From a policy perspective, identifying the factors or characteristics that contribute
most to the observed disparities in colonoscopy is important in designing effective
programs and prioritizing interventions. Decomposing income-related disparities in
colonoscopy use can help uncover factors that are potentially modifiable. Therefore, the
purpose of this study is to examine changes in income-related disparities in colonoscopy
use in pre-ACA and post-ACA years and to decompose the disparities into important
constituent factors.

METHODS
Data
This study used 2008-2016 BRFSS data, an annual, nationally representative
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam,
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff,
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public
health survey in the world; in 2016, the number of completed interviews was 486,303.
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors,
chronic diseases and conditions, access to health care, and use of preventive health
services in the United States.
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In 2008 the BRFSS began including questions about colonoscopies in even years.
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016.
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries
following the implementation of the ACA (Hamman and Kapinos 2015). One study used
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare
coverage, and socio-economic status before the Great Recession (2003-2005), during the
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt,
Pernenkil et al. 2017). These studies used a very short time frame beginning with the
implementation of the ACA, so the studies may underestimate the effects of policy
changes. The sample for this study consists of noninstitutionalized, insured elderly aged
65 to 75 who participated in the survey from the years 2008, 2010, 2012, 2014, and 2016.
For our analyses, only those insured who were in the age group 65 to 75 years were
included, bringing the sample size down to 446,981 adults. We excluded individuals with
missing values for variables of interest and those who refused to answer questions
relevant in creating the main measures for the study. Thus, the analysis sample consisted
of 349,899 participants (144,628 men and 205,271 women) aged 65 to 75 years.

Definition of the Measures Used
The variable of interest for the study is the self-reported receipt of a colonoscopy
in the previous 10 years. A respondent is considered to have received a colonoscopy if
the individual answered “colonoscopy” to the question, “was your last test a
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sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy
was received, the responses to the follow-up question were used: “how long has it been
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome
variable as a dichotomous measure of whether an individual was up-to-date with the
USPSTF screening recommendation. During our study period, the guidelines
recommended having a colonoscopy once every 10 years.
The literature has identified several sets of variables to explain variations in
colonoscopy use (Benarroch-Gampel, Sheffield et al. 2012, Centers for Disease Control
and Prevention 2013, Courtney, Paul et al. 2013, Howard, Guy et al. 2014, Ramdass,
Petraro et al. 2014, Hamman and Kapinos 2015, Partin, Gravely et al. 2016, Grzywacz,
Hussain et al. 2017). We included age, sex, race and ethnicity. Age was categorized into
five groups: 65-66, 67-68, 69-70, 71-72, and 73-75. Sex was classified into two
categories: male and female. Participants’ race and ethnicity was categorized into four
groups: non-Hispanic white, non-Hispanic Black, Hispanic, and other. We dichotomized
marital status as married or not married. We described geographic characteristics by
census region (Northeast, Midwest, South, and West). Based on previous studies
(Benarroch-Gampel, Sheffield et al. 2012, Hamman and Kapinos 2015, Solmi, Von
Wagner et al. 2015, Cooper, Kou et al. 2016), our analysis included household income
and educational attainment. We used a categorical measure of annual household income
with the following categories: lower than $10,000; $10,000 to $14,999; $15,000 to
$19,999; $20,000 to $24,999; $25,000 to $34,999; $35,000 to $49,999; $50,000 to
$74,999; and $75,000 or more. Educational attainment was classified into four categories:
did not graduate high school; graduated high school; attended college; and graduated
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from college. Racial and ethnic disparities in CRC screening had already been broadly
documented, and most studies found that individuals belonging to ethnic minorities were
less likely to adhere to screening guidelines; lower socio-economic status (indicating
dimensions such as income, education, and employment status) among ethnic minority
groups is considered the most likely explanation for this finding (Shih, Zhao et al. 2006,
Benarroch-Gampel, Sheffield et al. 2012, Burnett-Hartman, Mehta et al. 2016, Hong,
Tauscher et al. 2017). In addition, lower educational attainment is associated with lower
adherence to CRC screening guidelines (Gimeno Garcia 2012, Kobayashi, Wardle et al.
2014).
The final data set generated for this analysis includes two years of information
prior to the implementation of ACA (2008 and 2010) and three years of information
following the implementation of ACA (2012, 2014, and 2016). Since a large majority of
this group is covered by Medicare, the policy changes adopted by Medicare should have
significant impact on the use of colonoscopy. For controlling the time trade-off rates of
individuals and willingness to spend resources for improving future health status, we
incorporated two variables in the analysis: whether the individual exercised or not within
previous 30 days and whether the individual is a current smoker, former smoker, or never
smoked.

Concentration index
The concentration index has demonstrated its usefulness as a tool in measuring
health sector disparities. The concentration index measures the degree of disparity in the
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utilization of various medical care services or outcomes. To estimate the concentration
index, one variable must be used as the main metric to rank households on the basis of
levels of living or socioeconomic status. We can use household income as the measure to
calculate the concentration index in the use of colonoscopies. The standard concentration
index (CI), denoted below by CI, can be written as follows:
𝑛

2
𝐶𝐼 =
∑ 𝑦𝑖 𝑅𝑖 − 1
𝑛μ
𝑖=1

where 𝑛 is the sample size, 𝑦𝑖 is healthcare utilization of individual 𝑖, μ is its mean and
𝑅𝑖 =

𝑖
𝑁

is the fractional rank of individual 𝑖 in household income distribution. For a

given μ > 0, the maximum of the concentration index is when the poorest 𝑖 individuals
have a value of 𝑦𝑖 equal to zero and the richest 𝑛 − 𝑖 individuals have a value of 𝑦𝑖
equal to 1. In this case, the value of CI will be maximum at +14. If the poorest person
uses CRC screening and not anyone else, the CI will have the value of -1. If the richest
person uses CRC screening and not anyone else, the CI will have the value of +1. If CI
equals zero, then there is no income-related disparity in the distribution of CRC
screening. As this analysis have used a binary response indicating whether or not a
insured elderly had a recommended colonoscopy, normalized concentration index
employing the Wagstaff decomposition method was applied (Wagstaff 2005). Standard

4

𝐶𝐼 =

2
𝑛μ

∑𝑛𝑖=1 𝑦𝑖 𝑅𝑖 − 1 =

2
(𝑛−1)μ

𝑛−1

∑𝑖=1 𝑦𝑖 (= 0) 𝑅𝑖 − 1 +

2
(1)μ
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𝑛

∑𝑖=𝑛−1 𝑦𝑖 (= 1) 𝑅𝑖 = 0 − 1 + 2 = +1

errors for the normalized index correct for both autocorrelation and heteroscedasticity
(Cai, Coyte et al. 2017).

𝐶𝐼𝑛 =

𝐶𝐼
1−μ

Decomposition Analyses
We first compared the difference in concentration index between the pre- and
post-ACA periods. Decomposition analysis of the concentration index was used to
determine the impact of a range of sociodemographic variables on the disparity in
colonoscopy use. Decomposition analysis is based on partitioning of total disparity into
the precise disparities observed by each individual factor (van Doorslaer, Koolman et al.
2004). A logistic regression is applied with a linear estimation to allow for the correct
decomposition. The following equation shows the linear estimation of the logistic results
where β𝑛𝑘 are the average partial effects of each variable (𝑥) – yielding the likelihood of
a screening colonoscopy (𝑦).
𝑦𝑖 = ∑ β𝑛𝑘 𝑥𝑖𝑘 +𝜀𝑖
𝑘

The following equation shows the decomposition analysis comprised of average
partial effects of each 𝑥 as well as their means and individuals concentration index. In
this equation, the first expression shows the contribution of equivalized income, the
second expression shows effects of other socio-demographic variables perceived to
influence colonoscopy usage, and the final expression refers to the residual term.
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β𝑘 𝑥𝑟
𝑥𝑘
𝐺𝐶𝜀
𝐶𝐼𝑛 = (
) 𝐶𝐼𝑟 ∑(𝛽𝑘 ) 𝐶𝐼𝑘 +
μ
μ
μ
𝑘

We presented CIs prior to the ACA policy change (2008 and 2010) and after ACA
implementation (2012, 2014, and 2016). We identified the largest determinant of
disparity observed in pre-ACA years and post ACA years. Positive values of the overall
CIs suggest that colonoscopy use was concentrated among individuals with higher
household incomes. CIs were broken down by confounder and represented as
contributions to the overall income-related disparity in the use of colonoscopies with
percentage contributions in brackets. The percentage contribution is attained by dividing
the absolute contribution by the overall income-related disparity. We included age, sex,
race and ethnicity, marital status, household income, educational attainment, region of
residence, exercise, and smoking status as possible determinants.

RESULTS
Table 1 shows the descriptive statistics for pre-ACA years and post-ACA years in
the total sample. The data set had 349,899 respondents aged 65 to 75. The majority of
participants were female (59%), married (55%), exercised in the past 30 days (73%), and
had a colonoscopy in the past 10 years (68%). The receipt of colonoscopy increased from
63% in pre-ACA years to 70% in post-ACA years (Table 1).
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Table 2 presents the descriptive characteristics of the respondents by colonoscopy
use among insured elderly. Among the 349,899 insured elderly aged 65 to 75 years,
236,275 (67%) indicated that they had received colonoscopies in the previous 10 years.
The receipt of colonoscopy was highest among those aged 69-70 (68%). The receipt of
colonoscopy was more prevalent among high income than those with low incomes (77%
vs. 46%; p <.0001). About 74% of those graduated from college had colonoscopies
compared to 53% of those who did not graduate from high school (74% vs. 53%; p
<.0001). The receipt of colonoscopy was slightly higher among the respondents who
exercised in the past 30 days than those who did not (70% vs. 61%; p <.0001). In
addition, colonoscopy was more prevalent among former smokers or those never smoked
than the current smokers (70% and 68% vs. 53%; p<.0001).
Table 3 presents the decomposition of CIs in the use of colonoscopy in pre-ACA
and post-ACA years. Elasticity values in the first column shows the sensitivity of
colonoscopy use for each of the factors. The CI for each factor is presented in the second
column, which shows the distribution of each factor by income levels. It tests the levels
of influence for each factor according to income level. From pre-ACA to post-ACA
years, overall CIs decreased from 0.1935 to 0.1813. Positive values of the overall CIs
suggest that colonoscopy use was more concentrated among individuals with higher
household incomes. For example, a positive value for educational attainment (education –
attended college or graduated from college) in Table 3 indicates that educational
attainment has a pro-rich distribution. Lastly, the final two columns of Table 3 present,
respectively, the absolute and percentage contributions to overall income-related disparity
in the use of colonoscopies. The absolute contribution is the product of the elasticity and
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the partial concentration index for each of the factors, so it depends both on the impact of
each variable on the use of colonoscopy, and on its unequal distribution by household
income. The positive absolute contribution of a factor indicates that the factor contributes
to the measured pro-rich disparities in the use of colonoscopies. The percentage
contribution can be obtained by dividing the absolute contribution by the overall incomerelated disparity. The highest income group was consistently the largest contributor to
disparity in the use of colonoscopies in both pre-ACA (54%) and in post-ACA years
(79%). The highest income and highest educational attainment were the major
contributors to the existing disparity in the use of colonoscopies. Having a college degree
contributed approximately 31% to the observed CI for the use of colonoscopies in preACA years and 21% to CI in post-ACA years. Physical exercise in the previous 30 days
and being a non-smoker positively contributed to colonoscopy disparity in both the preACA and post-ACA years.
The concentration indices (CIs) for colonoscopy use in Figure 2 highlight the
income-related. The positive values of the CI observed suggest that colonoscopy use has
been more prevalent among the higher income individuals and the CI value has declined
slightly from 0.1935 in pre-ACA years to 0.1813 in post-ACA years (Table 3).

DISCUSSION
The aim of this study was to compare changes in income-related disparities in
colonoscopy use between pre-ACA and post-ACA years and to identify the contributors
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that affect the income-related disparities. Our concentration indices imply that significant
income-related disparity in the use of colonoscopies exists among elderly insured
individuals in the age group 65 to 75, and that disparities in the use of colonoscopy
lessened after the implementation of ACA. A plausible explanation for the observed
decline in disparities may be due to the reduction in cost-sharing. The results are
consistent with the findings of an earlier study which found that the expansions in the
coverage of CRC screening are associated with reductions in disparities (Hamman and
Kapinos 2015).
We found that income and educational attainment were the major contributors of
disparity in the use of colonoscopies. Decomposition analysis show that the highest
income group was consistently the largest contributor to disparity in pre-ACA (54%) and
post-ACA years (79%) and having a college degree contributed approximately 31% to
the observed disparities in pre-ACA years and 21% in post-ACA years. The previous
study that identified income and educational attainment as the most important factors
affecting observed disparity among insured population aged 50 to 64 years indicates that
lower income and educational attainment together accounted for 59% of the explained
disparity (Hamman and Kapinos 2015). Consistent with our study, a previous study
examining the cervical cancer screening across 67 countries showed that income and
educational attainment are the key determinants of disparities in uptake despite the
existence of national policy assuring equal access to preventive services (McKinnon,
Harper et al. 2011). Since income is such a significant contributor, policy makers should
focus on strategies to identify how to improve access to screening services by poorer
sections of the population. Reducing the financial barriers further may help but it is also
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possible that accessing services, especially preventive services, involves higher
opportunity cost for the poorer individuals than for richer individuals. In the short-run,
eliminating the remaining difference in cost-sharing between screening and therapeutic
colonoscopies could be an approach for reducing disparities in the use of colonoscopies
among Medicare beneficiaries (Hamman and Kapinos 2015).
In this analysis, we found that colonoscopy use has remained pro-rich even after
the introduction of ACA (CIs: 0.1935 in pre-ACA years to 0.1813 in post-ACA years).
Our literature review did not find similar studies in the USA although few international
studies can be used for comparing our results (Burns, Walsh et al. 2012, Walsh, Silles et
al. 2012, Carrieri and Wuebker 2013, Kim and Hwang 2016). To better understand how
the values of CIs in this study differ from other studies, we compared the CI values with
available international studies. A number of studies found pro-rich disparities in CRC
screening uptake in England (CI: 0.164), Ireland (CI: 0.070), and Korea (CI: 0.131)
although the CI values are lower than what was obtained for the US elderly population. In
addition, some studies reported pro-rich disparities in prostate cancer screenings in
Ireland (CIs: 0.169 in the 40-54 age group, 0.157 in the 55-69 age group, 0.230 in the 70
and over age group), gastric cancer screening (CI: 0.132) in Korea, mammography use
(CI:0.144) in France, and mammography use (CI:0.125) in Germany. Again, the CI
values are smaller than what we found in our empirical analysis. Lower disparity in
countries with national health insurance programs is expected but the existence of
disparity even in these countries point to the importance of examining other factors
associated with socioeconomics that directly or indirectly lower access to preventive
services. To identify how the USA can further improve the uptake of colonoscopies, it
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will be useful to analyze the proximate factors that have allowed other countries to
achieve much lower disparity. Disparity in the use of colonoscopies still persists in the
USA after the implementation of ACA in the US implying that coverage of screening
programs by health insurance is one of the important steps towards reducing disparity but
insurance coverage alone will not be sufficient to reduce the disparity by a significant
extent. One plausible explanation is that cancer screening uptake may be influenced by
other factors that are correlated with income. For instance, low income individuals may
have lower physical access due to distance or face greater restrictions in their work to
leave income earning activities for one full day. The loss of income due to absences from
work may also be higher for the poorer groups as they are more likely to be employed on
hourly basis. One study assessed the patterns and reasons for missed work related to
colonoscopies and found that 34% of working individuals missed work for more than one
day when they had their screenings scheduled on a Tuesday, Wednesday, or Thursday.
This study also found that 32% took the previous day off as well mainly for the need for
bowel preparation, 10% took the day after off, primarily as a precautionary measure after
sedation rather than in response symptoms, and 9% took both days off. Moreover,
colonoscopy procedures require a significant amount of time investment from friends and
family members. 45% of individuals had friends or family members who also took time
off work for the procedure (Dong, Kalmaz et al. 2011). These costs, to some extent, can
be diminished through patient education on the procedure, and by scheduling
colonoscopies on Mondays and Fridays (Dong, Kalmaz et al. 2011).
Compared to traditional regression analysis, CI has its strengths and limitations.
One strength is that because all respondents were included in the calculation of CI, results
122

are not likely to be biased by the small sample sizes present in some subgroups. Another
strength is that CI is especially sensitive to changes in socio-economic distribution. The
primary limitation of CI is that it can only be applied when a strict ranking of households
is available using a valid measure of socioeconomic status.
Despite these limitations, this study provides evidence of changes in incomerelated disparities in colonoscopy use among insured elderly from pre-ACA years to postACA years. Our findings indicate that the ACA’s removal of financial barriers may have
contributed towards observed decrease in the disparity of colonoscopy use. Interventions
aimed at reducing disparities should focus on improving screening in populations with
relatively low income and education. Further studies are needed to identify the barriers
that prevent low-income and low-educational attainment individuals from seeking
colonoscopy despite Medicare’s waiver of Part B deductibles for all colonoscopies and
elimination of coinsurance for screening colonoscopies.
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Table 4.4 Characteristics of Survey Participants Aged 65 to 75 Years: Behavioral Risk Factor Surveillance
System (BRFSS), 2008-2016
Total
Pre-ACA
Post ACA
Characteristic

N

N

N

Total
Age (years)
65-66
67-68
69-70
71-72
73-75
Sex
Male
Female
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other

349,899

Weighted %
100.0

78,424
72,261
65,746
56,989
76,479

23.0
20.7
18.6
15.9
21.8

27,686
25,928
22,953
20,739
28,271

22.7
20.5
17.9
16.3
22.6

50,738
46,333
42,793
36,250
48,208

23.2
20.8
18.9
15.7
21.4

144,628
205,271

48.4
51.6

49,856
75,721

48.0
52.0

94,772
129,550

48.6
51.4

300,176
23,541
11,393
14,789

78.7
9.2
7.1
5.1

107,573
8,262
4,523
5,219

79.4
8.6
7.1
5.0

192,603
15,279
6,870
9,570

78.3
9.5
7.1
5.2

Married
Region of Residence
Northeast
Midwest
South
West
Household income
Less than $10,000
$10,000 to less than $15,000
$15,000 to less than $20,000
$20,000 to less than $25,000
$25,000 to less than $35,000
$35,000 to less than $50,000
$50,000 to less than $75,000
$70,000 or more
Education
Did not graduate high school
Graduated High School
Attended College
Graduated from College
Colonoscopy within 10
years
Yes
No
Exercise in past 30 days
Yes
No
Smoking Status
Current smoker
Former smoker
Never smoked

191,812

62.9

67,832

65.7

123,980

61.4

63,156
83,992
117,730
85,021

17.9
22.2
37.6
22.3

21,448
27,263
45,098
31,768

18.3
22.1
37.6
22.0

41,708
56,729
72,632
53,253

17.7
22.3
37.6
22.4

14,258
23,717
30,639
41,080
51,045
61,885
55,472
71,803

4.1
6.1
8.3
10.9
14.0
17.6
16.5
22.5

6,171
9,974
12,442
16,334
20,179
22,442
17,758
20,277

4.6
6.4
8.8
11.7
15.2
17.8
15.6
20.0

8,087
13,743
18,197
24,746
30,866
39,443
37,714
51,526

3.9
6.0
8.1
10.5
13.3
17.5
16.9
23.8

28,997
107,851
92,346
120,705

12.4
30.3
28.3
29.0

13,251
43,068
31,705
37,553

11.4
32.2
24.3
32.0

15,746
64,783
60,641
83,152

12.9
29.2
30.5
27.4

236,275
113,624

67.2
32.8

78,958
46,619

63.5
36.5

157,317
67,005

69.2
30.8

254,285
95,614

72.2
27.8

89,570
36,007

72.2
27.8

164,715
59,607

72.2
27.8

40,547
149,275
160,077

11.2
44.0
44.8

15,127
55,012
55,438

11.1
44.9
44.1

25,420
94,263
104,639

11.3
43.5
45.2

127

125,577

Weighted %
100.0

224,322

Weighted %
100.0

Table 4.5 Descriptive characteristics of the respondents by colonoscopy use among insured elderly aged 65 to
75 Years, 2008-2016
Colonoscopy Uptake
Total
Variables
P-value
Yes
No
Age (years)
65-66

N

%

N

%

N

78,424

%

22.4

52,092

65.5

26,332

34.5

67-68
69-70
71-72
73-75
Sex
Male
Female

72,261
65,746
56,989
76,479

20.7
18.8
16.3
21.9

49,065
44,776
38,826
51,516

67.7
67.9
67.8
67.3

23,196
20,970
18,163
24,963

32.3
32.1
32.2
32.7

144,628
205,271

41.3
58.7

97,734
138,541

67.0
67.4

46,894
66,730

33.0
32.6

0.2031

Race/ethnicity
Non-Hispanic White

300,176

85.8

205,396

69.0

94,780

31.0

<.0001

Non-Hispanic Black
Hispanic
Other
Married
Region of Residence

23,541
11,393
14,789
191,812

6.7
3.3
4.2
54.8

15,638
6,539
8,702
137,617

67.2
54.0
57.7
70.3

7,903
4,854
6,087
54,195

32.8
46.0
42.3
29.7

<.0001

Northeast
Midwest
South
West
Household income
Less than $10,000
$10,000 to less than $15,000
$15,000 to less than $20,000
$20,000 to less than $25,000
$25,000 to less than $35,000

63,156
83,992
117,730
85,021

18.1
24.0
33.7
24.3

44,832
56,513
79,992
54,938

70.2
68.3
68.0
62.2

18,324
27,479
37,738
30,083

29.8
31.7
32.0
37.8

<.0001

14,258
23,717
30,639
41,080
51,045

4.1
6.8
8.8
11.7
14.6

7,015
12,602
17,438
25,215
33,674

46.0
52.4
56.0
61.5
65.7

7,243
11,115
13,201
15,865
17,371

54.0
47.6
44.0
38.5
34.3

<.0001

$35,000 to less than $50,000

61,885

17.7

43,352

69.4

18,533

30.6

$50,000 to less than $75,000
$70,000 or more
Education
Did not graduate high school
Graduated High School
Attended College

55,472
71,803

15.9
20.5

41,231
55,748

73.6
76.5

14,241
16,055

26.4
23.5

28,997
107,851
92,346

8.3
30.8
26.4

15,109
68,862
62,647

53.1
64.7
69.0

13,888
38,989
29,699

46.9
35.3
31.0

Graduated from College

120,705

34.5

89,657

74.0

31,048

26.0

95,614
254,285

27.3
72.7

58,488
177,787

60.9
69.6

37,126
76,498

39.1
30.4

<.0001

40,547
149,275
160,077
349,899

11.6
42.7
45.8
100.0

21,566
104,426
110,283
236,275

53.4
70.0
67.8
67.2

18,981
44,849
49,794
113,624

46.6
30.0
32.2
32.8

<.0001

Exercise in past 30 days
No
Yes
Smoking Status
Current smoker
Former smoker
Never smoked
Total
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<.0001

<.0001

Table 4.6 Decomposition Analysis of participation of colonoscopy among Insured Elderly: BRFSS,
2008-16
Pre ACA (2008, 2010)
Post ACA (2012, 2014, 2016)
Variables
Elasticit
Cont
%
Elasticit
Cont
%
CI
CI
y
r.
contr.
y
r.
contr.
Age (years)
65-66
1.000
1.000
67-68
0.003 0.045 0.001
0.288
0.006 0.027 0.001
0.326
69-70
0.005 0.004 0.000
-0.046
0.006 0.000 0.000
-0.005
71-72
0.005 0.027 0.001
-0.251
0.005 0.013 0.000
-0.143
73-75
0.008 0.085 0.003
-1.427
0.006 0.063 0.002
-0.871
Sex
Male
1.000
1.000
Female
0.054 0.200 0.043 -22.279
0.055 0.161 0.036 -19.638
Race/ethnicity
Non-Hispanic White
1.000
1.000
Non-Hispanic Black
0.002 0.088 0.001
-0.266
0.004 0.088 0.002
-0.823
Hispanic
-0.004 0.097 0.002
0.799
-0.004 0.104 0.002
0.823
Other
-0.003 0.017 0.000
0.113
-0.004 0.002 0.000
0.021
Marital status
Yes
1.000
1.000
No
-0.012 0.409 0.020
10.500
-0.012 0.434 0.021
11.673
Region of Residence
Northeast
1.000
1.000
Midwest
-0.005 0.015 0.000
0.143
-0.003 0.018 0.000
0.121
South
-0.008 0.051 0.002
0.789
-0.002 0.076 0.001
0.298
West
-0.018 0.045 0.003
-1.648
-0.017 0.066 0.004
-2.424
Household income
Less than $10,000
1.000
1.000
$10,000 to less than
$15,000
0.002 0.217 0.002
-1.023
0.003 0.207 0.003
-1.367
$15,000 to less than
$20,000
0.006 0.243 0.006
-2.939
0.005 0.234 0.005
-2.604
$20,000 to less than
$25,000
0.011 0.229 0.010
-5.334
0.011 0.224 0.010
-5.408
$25,000 to less than
$35,000
0.021 0.133 0.011
-5.815
0.017 0.158 0.011
-6.003
$35,000 to less than
$50,000
0.028 0.078 0.009
4.490
0.027 0.008 0.001
0.460
$50,000 to less than
$75,000
0.030 0.277 0.033
17.235
0.032 0.241 0.030
16.792
$70,000 or more
0.041 0.641 0.104
53.763
0.049 0.725 0.143
78.640
Education
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Did not graduate high
school
Graduated High School
Attended College
Graduated from College
Exercise in past 30 days
No
Yes
Smoking Status
Current smoker
Former smoker
Never smoked
Concentration index (CI)

1.000
0.018
0.017
0.031
1.000
0.033
1.000
0.058
0.044

1.000
0.242
0.018
0.471

0.017
0.001
0.059

-8.972
0.618
30.554

0.013
0.021
0.024

0.196
0.051
0.413

0.010
0.004
0.039

-5.610
2.367
21.414

0.217

0.027

14.760

0.051
0.057
0.181

0.010
0.010

5.746
5.261

0.206

0.027

13.913

1.000
0.031

0.072
0.026
0.193

0.017
0.005

8.694
2.377

1.000
0.051
0.042
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Figure 4.6. Concentration curve of colonoscopy use by rank of individuals by household
income level
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Figure 4.7 Concentration Index for colonoscopy use
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CHAPTER 5
SUMMARY, IMPLICATIONS, AND RECOMMENDATIONS

The results of this study indicated that the use of colonoscopies increased among
the elderly insured after the implementation of the ACA cost-sharing rule for preventive
services. The receipt of colonoscopies among the elderly insured increased from 64% in
pre-ACA years to 69% in post-ACA years. After controlling for a number of individual
and geographic factors, we found that elderly insured in the age group 65 to 75 years
were 1.15 times more likely to be up-to-date with colonoscopy screenings than they were
before implementation of the ACA. Although the analysis could not incorporate out-ofpocket expenses directly into the model due to lack of data, it is likely that the increase in
colonoscopy uptake observed in the post-ACA years was due to reduction in costsharing. Increased coverage of colonoscopies appeared to be more pronounced among
elderly insured who were less educated and in lower household income groups. In fact,
increases in colonoscopy uptake were greatest among the lower income and lower
education groups when comparing pre-ACA percentages to post-ACA percentages.
However, even with higher coverage of colonoscopies after ACA implementation, only
about half of the elderly insured in the age group 65-75 years with a household income
less than $15,000 received a recommended colonoscopy. In fact, post-ACA
implementation, 56% of elderly insured aged 65-75 years without a high school diploma
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had received a colonoscopy in the last 10 years. Even after significant reductions in outof-pocket expenses for colonoscopy receipt, the coverage of colonoscopies remains
suboptimal; it is much lower than the national goal of 80% by 2018 and the HP2020 goal
of 71%. To achieve a higher rate of progress toward the national goal, we must identify
specific approaches that encourage socioeconomically disadvantaged elderly to seek
colonoscopies.
However, we must stress again that our study did find a significant increase in
colonoscopy use among elderly insured with lower socioeconomic status after
implementation of the ACA. The increase may, in part, have been due to the removal of
out-of-pocket costs, since previous studies found that financial barriers reduced coverage
of cancer screening (Busch, Barry et al. 2006, Goodwin and Anderson 2012, Hamman
and Kapinos 2015), and colonoscopies are expensive (Pyenson, Scammell et al. 2014). It
is also possible that the increase in the receipt of colonoscopies among lower
socioeconomic groups reflected both the continued increase of nationwide trends that and
the proliferation of private health plans (Klabunde, Cronin et al. 2011, Shapiro, Klabunde
et al. 2012, Wernli, Hubbard et al. 2014). The increase in CRC screenings was clearly
universal across socioeconomic status and was not limited to subjects with lower income
and lower levels of education. However, despite the improvements in colonoscopy uptake
over the years, the poorest and the most socially disadvantaged groups represented the
highest potential for improvement, given their relatively low rates of colonoscopy use. To
achieve the target screening rate, policy makers must use additional interventions beyond
lowering the barriers to access.
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Our study results in the second manuscript suggested a significant income-related
disparity in the use of colonoscopies among the elderly insured aged 65 to 75, and that
disparities in colonoscopy use were lessened after the implementation of the ACA. We
found that income and educational attainment levels were the major contributors to the
existing disparity in the use of colonoscopies. Decomposition showed that the highest
income group was consistently the largest contributor to the disparity in pre-ACA
colonoscopy receipt (54%) and in post-ACA colonoscopy receipt (79%), and that having
a college degree contributed approximately 31% to the observed disparities in pre-ACA
years and 21% in post-ACA years.
Since income appears to be such a significant factor, policy makers should focus
on the further reduction of financial barriers in colonoscopy use among the elderly
insured. Eliminating cost-sharing for therapeutic colonoscopies could be the next policy
reform to be considered in improving adherence to CRC screening guidelines (Hamman
and Kapinos 2015).
Policy makers must also consider non-medical costs in order to improve screening
rates more rapidly. Cost is not the only barrier to receipt of colonoscopies. Other barriers
include perceived loss of utility associated with bowel preparation prior to the test,
logistical challenges, lack of a physician’s recommendation for CRC screening, and
belief that CRC screening is unimportant or unnecessary (Benarroch-Gampel, Sheffield
et al. 2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et al. 2013,
Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos 2015,
Partin, Gravely et al. 2016, Grzywacz, Hussain et al. 2017) .
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Research has shown that patients’ perception of insurance coverage can deter
them from receipt of CRC screening (Courtney, Paul et al. 2013, Zhao, Okoro et al.
2018). This indicates a need for improved awareness of the ACA’s cost-sharing reduction
provision among the elderly insured population. The Medicare program should ensure
that all Medicare beneficiaries are aware of the new policy, which states that Part B
provides screening colonoscopies with no deductible or coinsurance.
Another problem to address is that individuals with low income and/or unstable
employment may have more difficulty in leaving work to receive preventive services. A
previous study assessed the patterns and reasons for missed work related to screening
colonoscopies, and the researchers found that 34% of working individuals missed work
more than one day when they had their screening on a Tuesday, Wednesday, or
Thursday. According to the study, 32% of participants requested sick or vacation leave
for the day prior to the screening, mainly in anticipation of the bowel preparation; 10%
requested leave for the day after the procedure, primarily as a precautionary measure
following sedation rather than in response to true symptoms; and 9% requested leave for
both days.
Finally, colonoscopy procedures require a significant amount of time investment
from friends and family members. 45% of individuals had friends or family members
who also took leave from work because of the procedure (Dong, Kalmaz et al. 2011). All
these non-medical costs may be diminished through patient education about bowel
preparation and what to expect before and after the procedure, and by scheduling more
screening colonoscopies on Monday and Fridays (Dong, Kalmaz et al. 2011).
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Researchers and policy makers have studied the effects of cost-sharing reductions
on the utilization of preventive health care in great detail, but surprisingly, only a few
studies have assessed the effect of cost-sharing reductions on colonoscopies among
elderly insured (including Medicare beneficiaries), following the implementation of the
ACA (Hamman and Kapinos 2015, Cooper, Kou et al. 2016). The few studies that have
examined this issue used a very short time-frame beginning with the implementation of
the ACA, so they may have underestimated the effects of the ACA cost-sharing
reduction. Furthermore, these studies yielded variable results concerning the receipt of
colonoscopies following the changes in coverage post-ACA (Fedewa, Goodman et al.
2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016); and they did not determine
whether eliminating financial barriers to the receipt of colonoscopies might affect
socioeconomically vulnerable Medicare beneficiaries more than it affected other groups.
Moreover, these studies did not examine the ACA’s impact on screening disparities
among the elderly insured. It is true that some of the socioeconomically vulnerable
elderly may be enrolled in Medicaid; and in those cases, the individuals would have
received colonoscopies with no out-of-pocket expenses in the pre-ACA years. However,
this should not affect the results of our study significantly as almost all elderly are
enrolled in Medicare and only a relatively small percentage are enrolled in Medicaid
(meaning Medicaid only or dually eligible) (Grabowski, 2012). Thus, to address these
gaps in current research, this study examined the changes in colonoscopy use among the
elderly insured population, including Medicare beneficiaries, following the
implementation of the ACA policy for preventive services.
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Previous studies found divergent results regarding post-ACA changes in CRC
screenings among the elderly and Medicare beneficiaries (Fedewa, Goodman et al. 2015,
Hamman and Kapinos 2015, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016).
Some studies found an increase in the receipt of CRC screenings (Fedewa, Goodman et
al. 2015, Hamman and Kapinos 2015), while others found no change in the use of any
cancer screening procedure (Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016).
However, unlike these studies, our study had access to a longer time frame, which
allowed us to examine the effects of ACA policy changes on colonoscopy use in greater
detail. Using a longer time frame, and controlling for many other potential factors
affecting colonoscopy uptake (including the availability of health care providers in the
area – a variable never used before), we found a significant effect of policy change on
colonoscopy use. The new supply-side variable showed us that the availability of GIs in a
geographic area did affect the likelihood of receiving a colonoscopy within the
recommended time frame. We also enhanced the body of evidence surrounding changes
in income-related disparities in colonoscopy use among the elderly insured from preACA years to post-ACA years. Our findings indicate that the ACA’s removal of financial
barriers may contribute to the observed decrease in the disparity of colonoscopy use.
This study has several limitations. First, the BRFSS is based on self-reports,
which may be subject to recall bias. True screening rates are more likely less than 50%
for adults aged 50 or older (Paskett and Khuri 2015). Therefore, we faced a challenge in
establishing an accurate level of CRC screenings; and we were unable to perform a crosscheck with medical records using current data (Ferrante, Ohman-Strickland et al. 2008,
Schenck, Klabunde et al. 2008). Second, there is also the possibility of selection bias in
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this type of survey, as less-healthy patients may not be included in the sample. Third, the
BRFSS does not include information about actual out-of-pocket expenditures or other
possible determinants of screening such as opportunity, cost of time or difficulty in
scheduling colonoscopies. Fourth, this study could not distinguish between screening and
diagnostic colonoscopies. Nonetheless, given the fact that around 40% of adults who
should receive CRC screenings do not receive them (Joseph, King et al. 2012, Hamman
and Kapinos 2015, Paskett and Khuri 2015), finding an increase in all types of
colonoscopies as a result of the Affordable Care Act does suggest an improvement in
CRC detection. Fifth, gastroenterologists are not the only providers of colonoscopy, and
licensed providers vary by region (Benarroch-Gampel, Sheffield et al. 2012, Joseph,
Meester et al. 2016). Sixth, there may be historical threats to validity. Increasing
awareness over time and social norms in support of CRC may affect the rate of
colonoscopy use. Seventh, this study could not assess public awareness of CRC. Finally,
in 2011 BRFSS changed its weighting methodology with the inclusion of cellular phoneonly respondents. Cellular phone respondents are likely to be different from other
respondents in terms of age and risk of CRC. Therefore, this additional approach of
selecting respondents may have affected the sample of 2011 compared to samples from
the pre-2011 period.
In summary, our results confirmed that there was a statistically significant
increase in colonoscopy use among the elderly insured aged 65 to 75 years after the
implementation of the ACA. There was a significant income-related disparity in the use
of colonoscopies among the insured elderly aged 65 to 75, and disparities in colonoscopy
use lessened after the implementation of the ACA. Income and educational attainment
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levels were the major contributors to those disparities which still exist. Although
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for
screening colonoscopies, individuals are still subject to out-of-pocket medical expenses
for therapeutic colonoscopies (Hamman and Kapinos 2015). Our results indicate that the
ACA’s reduction of financial barriers has improved usage of CRC screening, and further
improvements will be possible if the costs associated with therapeutic colonoscopies can
be reduced or eliminated. Policy makers should also try to understand other related
expenses, both medical and non-medical, associated with the receipt of colonoscopies by
the elderly (Dong, Kalmaz et al. 2011, Petryszyn, Kempinski et al. 2014). Reducing these
costs will also help achieve the national target rate of colonoscopy use. Interventions
aimed at reducing disparities should focus on improving screening in populations with
low household incomes and low educational attainment. Moreover, our results indicate
that greater provider supply has been associated with increased use of colonoscopies. An
increased supply of providers may have little beneficial effect on race and ethnic
disparities in the receipt of colonoscopies or on geographic disparities in the receipt of
colonoscopies (Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 2017).
Interventions should focus on improving screening in populations living in rural areas
and among minorities. A recent study reported that the estimated colonoscopist capacity
was sufficient to screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016).
However, colonoscopies vary in quality, and high-quality colonoscopies take
considerably more time than that which the average physician spends on such a
procedure (Vicari 2010). If a particular area has a short supply of gastroenterologists,
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short-run alternatives may be possible, such as training primary care providers to conduct
colonoscopies (Selby, Cornuz et al. 2016).
The results of this study indicated that the use of colonoscopies increased among
the elderly insured after the implementation of the ACA cost-sharing rule for preventive
services. Reduction of financial barriers has been effective in improving CRC screening,
and further reduction in financial barriers is likely to improve uptake of CRC screening in
the future. The financial barriers are due not only to medical care costs but also to other
non-medical expenses, and policy makers should consider how to improve access to
preventive services by considering all the potential barriers to access. In general,
lowering out-of-pocket expenses for colonoscopies has improved receipt of
colonoscopies by all elderly groups; but the increase in coverage was higher for poorer
individuals and individuals with low educational attainment. Therefore, reduction in outof-pocket expenses benefited the disadvantaged elderly population at a higher rate than
other elderly groups.
This study will contribute to advancing knowledge about the effect of reduction in
cost-sharing on the receipt of colonoscopies among the elderly insured. It is critically
important to know whether reduction of financial barriers alone can improve adherence to
CRC screenings in order to achieve the national goal of 80% by 2018 target and the
HP2020 goal of 71%. Reduction in financial expenses alone may not be enough to reach
the goal, in which case these analyses will be able to indicate other policy options for
improving coverage of colonoscopies. The study will provide scientific evidence on
effect of cost-sharing reduction on the receipt of colonoscopies among the elderly insured
as well as other policy options for improving adherence to CRC screening.
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Under current law, Medicare waives coinsurance and deductibles for
colonoscopies. However, when a polyp is discovered and removed, the procedure is
reclassiﬁed as therapeutic for Medicare billing purposes and beneficiaries become
responsible for paying 20% coinsurance. Therefore, Medicare beneficiaries may face
unexpected out-of-pocket liabilities when a polyp is detected and removed during a
colonoscopy. The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R.
1017/S. 479 worked to correct an oversight in current law that requires Medicare
beneﬁciaries to cover the cost of their copayment for a free screening colonoscopy if a
polyp was discovered and removed during the procedure. This study will provide
scientific evidence regarding the benefits of cost-sharing reductions on the receipt of
colonoscopies among Medicare beneficiaries, thus supporting the Congressional bill
which proposes to close remaining Medicare loophole. As a next step, we will prepare a
manuscript to submit for the American Journal of Public Health and then a second
manuscript to submit to Medical Care. I will also share my findings, including policy
implications, at the American Public Health Association annual meeting in 2018. Finally,
this dissertation will lay a foundation for a grant I plan to pursue (from, for example, an
R03 small research grant program) to conduct a more in-depth investigation of racial and
ethnic disparities in colonoscopy use in relation to physician availability.
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